TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-192823	Viral mRNA Translation	6.71806849369288e-06	-11.9107098712779	84	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-156902	Peptide chain elongation	6.71806849369288e-06	-11.9107098712779	84	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-72764	Eukaryotic Translation Termination	7.74936074070869e-06	-11.7679002030709	85	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-156842	Eukaryotic Translation Elongation	1.17347608885114e-05	-11.3529551047946	88	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.34175191997864e-05	-11.2189493019454	89	14	0.0416666666666667	336	8202	6209,6159,6133,6158,6210,6134,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL28,RPS15A,RPL10,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-3000157	Laminin interactions	2.52705285339608e-05	-10.5858717213116	23	7	0.0208333333333333	336	8202	3910,3913,3685,3909,3675,3691,3912	LAMA4,LAMB2,ITGAV,LAMA3,ITGA3,ITGB4,LAMB1
R-HSA-72689	Formation of a pool of free 40S subunits	2.54458800458558e-05	-10.5789567123217	94	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	2.74927961672347e-05	-10.5015865451637	107	15	0.0446428571428571	336	8202	6209,6159,6133,10952,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,SEC61B,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-3000171	Non-integrin membrane-ECM interactions	3.92811104017527e-05	-10.1447668059938	42	9	0.0267857142857143	336	8202	3910,3909,375790,3912,3913,87,3685,3691,780	LAMA4,LAMA3,AGRN,LAMB1,LAMB2,ACTN1,ITGAV,ITGB4,DDR1
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	8.01231146031132e-05	-9.43194617369467	104	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	8.90864695651727e-05	-9.32590309175098	105	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-927802	Nonsense-Mediated Decay (NMD)	9.8909564142335e-05	-9.22130461883092	106	14	0.0416666666666667	336	8202	6209,6159,6133,6158,6210,6134,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL28,RPS15A,RPL10,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	9.8909564142335e-05	-9.22130461883092	106	14	0.0416666666666667	336	8202	6209,6159,6133,6158,6210,6134,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL28,RPS15A,RPL10,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-168254	Influenza Infection	0.00010037848978412	-9.20656261883851	147	17	0.0505952380952381	336	8202	6209,6159,6133,6160,6235,6142,3303,9636,23521,3304,6164,6189,6158,6210,6134,6170,6207	RPS15,RPL29,RPL9,RPL31,RPS29,RPL18A,HSPA1A,ISG15,RPL13A,HSPA1B,RPL34,RPS3A,RPL28,RPS15A,RPL10,RPL39,RPS13
R-HSA-168255	Influenza Life Cycle	0.000130765315136256	-8.9421063289055	136	16	0.0476190476190476	336	8202	6209,6159,6133,6160,6235,6142,3303,23521,3304,6164,6189,6158,6210,6134,6170,6207	RPS15,RPL29,RPL9,RPL31,RPS29,RPL18A,HSPA1A,RPL13A,HSPA1B,RPL34,RPS3A,RPL28,RPS15A,RPL10,RPL39,RPS13
R-HSA-72737	Cap-dependent Translation Initiation	0.000180014288680217	-8.62247432866785	112	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-72613	Eukaryotic Translation Initiation	0.000180014288680217	-8.62247432866785	112	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-1643685	Disease	0.000201829770248999	-8.5080859373921	657	46	0.136904761904762	336	8202	6209,375790,5721,6235,3978,5720,54894,1026,3303,23521,57534,6164,2261,182,4193,6464,6134,6170,2232,5290,6774,60489,6207,2254,6159,6133,6160,5295,6142,54492,6829,1956,9636,3304,51616,6189,3667,6827,6158,6210,2263,160,1462,6400,6772,1174	RPS15,AGRN,PSME2,RPS29,LIG1,PSME1,RNF43,CDKN1A,HSPA1A,RPL13A,MIB1,RPL34,FGFR3,JAG1,MDM2,SHC1,RPL10,RPL39,FDXR,PIK3CA,STAT3,APOBEC3G,RPS13,FGF9,RPL29,RPL9,RPL31,PIK3R1,RPL18A,NEURL1B,SUPT5H,EGFR,ISG15,HSPA1B,TAF9B,RPS3A,IRS1,SUPT4H1,RPL28,RPS15A,FGFR2,AP2A1,VCAN,SEL1L,STAT1,AP1S1
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.000640748976538136	-7.35287279000871	5	3	0.00892857142857143	336	8202	836,840,317	CASP3,CASP7,APAF1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.000640748976538136	-7.35287279000871	5	3	0.00892857142857143	336	8202	836,840,317	CASP3,CASP7,APAF1
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.000666528230123015	-7.31342806346902	127	14	0.0416666666666667	336	8202	6209,6159,6133,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-72766	Translation	0.000909700902955108	-7.00239469055116	146	15	0.0446428571428571	336	8202	6209,6159,6133,10952,6134,6210,6158,6170,6160,6235,6142,23521,6164,6207,6189	RPS15,RPL29,RPL9,SEC61B,RPL10,RPS15A,RPL28,RPL39,RPL31,RPS29,RPL18A,RPL13A,RPL34,RPS13,RPS3A
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.00105421166771524	-6.85496202576601	12	4	0.0119047619047619	336	8202	836,2934,7431,840	CASP3,GSN,VIM,CASP7
R-HSA-3371571	HSF1-dependent transactivation	0.00165711328967234	-6.40267817252341	22	5	0.0148809523809524	336	8202	817,3337,3306,3303,3304	CAMK2D,DNAJB1,HSPA2,HSPA1A,HSPA1B
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.00167339130317556	-6.39290299121467	2	2	0.00595238095238095	336	8202	3303,3304	HSPA1A,HSPA1B
R-HSA-3371568	Attenuation phase	0.00199746851584335	-6.21587464222861	14	4	0.0119047619047619	336	8202	3337,3306,3303,3304	DNAJB1,HSPA2,HSPA1A,HSPA1B
R-HSA-5663205	Infectious disease	0.00205638988996101	-6.18680331417265	347	26	0.0773809523809524	336	8202	6209,6159,6133,5721,6160,6235,3978,6142,5720,6829,3303,9636,23521,3304,6164,51616,6189,6827,6158,6210,6134,6170,160,1174,60489,6207	RPS15,RPL29,RPL9,PSME2,RPL31,RPS29,LIG1,RPL18A,PSME1,SUPT5H,HSPA1A,ISG15,RPL13A,HSPA1B,RPL34,TAF9B,RPS3A,SUPT4H1,RPL28,RPS15A,RPL10,RPL39,AP2A1,AP1S1,APOBEC3G,RPS13
R-HSA-111471	Apoptotic factor-mediated response	0.00210874293229513	-6.16166327571842	7	3	0.00892857142857143	336	8202	836,840,317	CASP3,CASP7,APAF1
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.00210874293229513	-6.16166327571842	7	3	0.00892857142857143	336	8202	81607,25945,5818	PVRL4,PVRL3,PVRL1
R-HSA-1226099	Signaling by FGFR in disease	0.0021538345675393	-6.14050550563969	45	7	0.0208333333333333	336	8202	2261,2254,6774,2263,5295,6772,5290	FGFR3,FGF9,STAT3,FGFR2,PIK3R1,STAT1,PIK3CA
R-HSA-1430728	Metabolism	0.00224042891805151	-6.10108795017239	1691	91	0.270833333333333	336	8202	1591,9060,1728,375790,5721,3635,27242,57214,113278,6513,3074,9123,10162,5720,79642,6389,8895,79586,5331,85441,1890,6821,548596,64428,5290,3032,7385,2941,1738,204962,10484,7390,5468,1371,6303,8612,93100,7263,123,54331,4047,53905,51363,8821,51495,8714,4048,3636,4719,8760,6819,84803,51477,2053,2950,2937,1119,2799,373156,8824,3038,6307,1384,2232,51582,8694,960,5631,6576,223,3156,4907,56603,516,5236,10678,5295,5836,7108,9517,51129,847,50484,1462,51,5243,4190,66002,37,2876,2582	CYP24A1,PAPSS2,NQO1,AGRN,PSME2,INPP5D,TNFRSF21,CEMIP,SLC52A3,SLC2A1,HEXB,SLC16A3,LPCAT3,PSME1,ARSJ,SDHA,CPNE3,CHPF,PLCB3,HELZ2,TYMP,SUOX,CKMT1A,NARFL,PIK3CA,HADHB,UQCRC2,GSTA4,DLD,SLC44A5,SEC23A,UROS,PPARG,CPOX,SAT1,PLPP2,NAPRT,TST,PLIN2,GNG2,LSS,DUOX1,CHST15,INPP4B,HACD3,ABCC3,LTA4H,INPPL1,NDUFS1,CDS2,SULT1C2,GPAT3,ISYNA1,EPHX2,GSTP1,GSS,CHKA,GNS,GSTK1,CES2,HAS3,MSMO1,CRAT,FDXR,AZIN1,DGAT1,CD44,PRPS1,SLC25A1,ALDH9A1,HMGCR,NT5E,CYP26B1,ATP5G1,PGM1,B3GNT2,PIK3R1,PYGL,TM7SF2,SPTLC2,ANGPTL4,CAT,RRM2B,VCAN,ACOX1,ABCB1,MDH1,CYP4F12,ACADVL,GPX1,GALE
R-HSA-202733	Cell surface interactions at the vascular wall	0.00231620569350578	-6.06782490909346	99	11	0.0327380952380952	336	8202	2335,6464,3675,3635,5295,9123,5290,3685,5627,960,965	FN1,SHC1,ITGA3,INPP5D,PIK3R1,SLC16A3,PIK3CA,ITGAV,PROS1,CD44,CD58
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.0025005667950754	-5.99123785477447	24	5	0.0148809523809524	336	8202	10484,6892,3107,64167,6890	SEC23A,TAPBP,HLA-C,ERAP2,TAP1
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.00263675876101233	-5.9382048581574	15	4	0.0119047619047619	336	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.00263675876101233	-5.9382048581574	15	4	0.0119047619047619	336	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-2262752	Cellular responses to stress	0.00345705394259141	-5.66733851429068	379	27	0.0803571428571429	336	8202	9134,23043,10808,3397,475,23466,3337,1026,2950,3303,3304,1912,3725,847,1031,6118,817,4193,55062,3091,653604,51434,112399,6774,11065,3306,2876	CCNE2,TNIK,HSPH1,ID1,ATOX1,CBX6,DNAJB1,CDKN1A,GSTP1,HSPA1A,HSPA1B,PHC2,JUN,CAT,CDKN2C,RPA2,CAMK2D,MDM2,WIPI1,HIF1A,HIST2H3D,ANAPC7,EGLN3,STAT3,UBE2C,HSPA2,GPX1
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.00411227908140157	-5.49377788314168	38	6	0.0178571428571429	336	8202	836,2934,7431,5588,840,4000	CASP3,GSN,VIM,PRKCQ,CASP7,LMNA
R-HSA-2142845	Hyaluronan metabolism	0.00430883415324707	-5.44708790954421	17	4	0.0119047619047619	336	8202	960,3038,57214,3074	CD44,HAS3,CEMIP,HEXB
R-HSA-446107	Type I hemidesmosome assembly	0.00476007830035344	-5.34749116122002	9	3	0.00892857142857143	336	8202	1308,3909,3691	COL17A1,LAMA3,ITGB4
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.00488385373993925	-5.32182066995948	3	2	0.00595238095238095	336	8202	37,3032	ACADVL,HADHB
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.00536361704237557	-5.22811671015024	18	4	0.0119047619047619	336	8202	6774,5295,6772,5290	STAT3,PIK3R1,STAT1,PIK3CA
R-HSA-1839124	FGFR1 mutant receptor activation	0.00590838334539132	-5.13138303060362	29	5	0.0148809523809524	336	8202	2254,6774,5295,6772,5290	FGF9,STAT3,PIK3R1,STAT1,PIK3CA
R-HSA-909733	Interferon alpha/beta signaling	0.00632165088727467	-5.06377488859349	68	8	0.0238095238095238	336	8202	10410,11274,6772,4940,3107,6773,9636,3659	IFITM3,USP18,STAT1,OAS3,HLA-C,STAT2,ISG15,IRF1
R-HSA-1474244	Extracellular matrix organization	0.00657750297263461	-5.02410009311004	267	20	0.0595238095238095	336	8202	3910,836,1308,1292,2335,375790,87,780,650,3909,3675,1462,1291,3912,3913,3685,3691,960,4325,823	LAMA4,CASP3,COL17A1,COL6A2,FN1,AGRN,ACTN1,DDR1,BMP2,LAMA3,ITGA3,VCAN,COL6A1,LAMB1,LAMB2,ITGAV,ITGB4,CD44,MMP16,CAPN1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.00657800930707635	-5.02402311633693	19	4	0.0119047619047619	336	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.00657800930707635	-5.02402311633693	19	4	0.0119047619047619	336	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-1643713	Signaling by EGFR in Cancer	0.00657800930707635	-5.02402311633693	19	4	0.0119047619047619	336	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-74259	Purine catabolism	0.00659550437238523	-5.02136701774091	10	3	0.00892857142857143	336	8202	847,2876,4907	CAT,GPX1,NT5E
R-HSA-1483257	Phospholipid metabolism	0.00677404501095414	-4.9946568799446	146	13	0.0386904761904762	336	8202	3636,8760,3635,84803,5295,8821,5290,3032,10162,8694,8895,204962,1119	INPPL1,CDS2,INPP5D,GPAT3,PIK3R1,INPP4B,PIK3CA,HADHB,LPCAT3,DGAT1,CPNE3,SLC44A5,CHKA
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.00685708685123087	-4.98247258469175	30	5	0.0148809523809524	336	8202	182,54492,92737,57534,23220	JAG1,NEURL1B,DNER,MIB1,DTX4
R-HSA-3000178	ECM proteoglycans	0.0074996797265272	-4.89289496248138	56	7	0.0208333333333333	336	8202	3910,3913,3685,3909,375790,1462,3912	LAMA4,LAMB2,ITGAV,LAMA3,AGRN,VCAN,LAMB1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.00774693882839213	-4.86045750353082	85	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-556833	Metabolism of lipids and lipoproteins	0.00932095974909698	-4.67548967821552	628	38	0.113095238095238	336	8202	1591,3636,8760,3635,27242,84803,3074,10162,79642,2053,8895,1119,85441,6307,1384,2232,5290,3032,8694,204962,6576,3156,10484,5468,5295,8612,7108,9517,51129,123,4047,51,8821,51495,8714,37,4048,2876	CYP24A1,INPPL1,CDS2,INPP5D,TNFRSF21,GPAT3,HEXB,LPCAT3,ARSJ,EPHX2,CPNE3,CHKA,HELZ2,MSMO1,CRAT,FDXR,PIK3CA,HADHB,DGAT1,SLC44A5,SLC25A1,HMGCR,SEC23A,PPARG,PIK3R1,PLPP2,TM7SF2,SPTLC2,ANGPTL4,PLIN2,LSS,ACOX1,INPP4B,HACD3,ABCC3,ACADVL,LTA4H,GPX1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.00998097449108093	-4.60707454902878	104	10	0.0297619047619048	336	8202	3667,2254,2261,4193,6464,2263,5295,5290,1026,1956	IRS1,FGF9,FGFR3,MDM2,SHC1,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.0103332715000838	-4.57238634704586	33	5	0.0148809523809524	336	8202	3636,3635,5295,8821,5290	INPPL1,INPP5D,PIK3R1,INPP4B,PIK3CA
R-HSA-5655332	Signaling by FGFR3 in disease	0.011271325594806	-4.48549333630287	22	4	0.0119047619047619	336	8202	2261,2254,5295,5290	FGFR3,FGF9,PIK3R1,PIK3CA
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0118617428925891	-4.43443694067919	61	7	0.0208333333333333	336	8202	3667,2261,2254,2263,1956,5295,5290	IRS1,FGFR3,FGF9,FGFR2,EGFR,PIK3R1,PIK3CA
R-HSA-1630316	Glycosaminoglycan metabolism	0.0118932223705841	-4.43178658980953	123	11	0.0327380952380952	336	8202	2799,10678,9060,375790,3038,57214,1462,51363,3074,960,79586	GNS,B3GNT2,PAPSS2,AGRN,HAS3,CEMIP,VCAN,CHST15,HEXB,CD44,CHPF
R-HSA-191273	Cholesterol biosynthesis	0.0132132207995688	-4.32653737490721	23	4	0.0119047619047619	336	8202	7108,4047,6307,3156	TM7SF2,LSS,MSMO1,HMGCR
R-HSA-5663202	Diseases of signal transduction	0.0138575748492713	-4.27892327533031	268	19	0.056547619047619	336	8202	2254,5721,5295,5720,54894,1026,54492,1956,57534,3667,2261,4193,182,6464,2263,5290,6772,6400,6774	FGF9,PSME2,PIK3R1,PSME1,RNF43,CDKN1A,NEURL1B,EGFR,MIB1,IRS1,FGFR3,MDM2,JAG1,SHC1,FGFR2,PIK3CA,STAT1,SEL1L,STAT3
R-HSA-109581	Apoptosis	0.0140585420362016	-4.26452509383689	160	13	0.0386904761904762	336	8202	836,2934,840,5721,581,8737,7431,5720,5588,317,2810,4000,355	CASP3,GSN,CASP7,PSME2,BAX,RIPK1,VIM,PSME1,PRKCQ,APAF1,SFN,LMNA,FAS
R-HSA-157118	Signaling by NOTCH	0.014472838222012	-4.23548161230582	110	10	0.0297619047619048	336	8202	3725,182,3091,5986,6400,23220,7088,54492,92737,57534	JUN,JAG1,HIF1A,RFNG,SEL1L,DTX4,TLE1,NEURL1B,DNER,MIB1
R-HSA-5655302	Signaling by FGFR1 in disease	0.0148567740503342	-4.20929935273939	36	5	0.0148809523809524	336	8202	2254,6774,5295,6772,5290	FGF9,STAT3,PIK3R1,STAT1,PIK3CA
R-HSA-5365859	RA biosynthesis pathway	0.0153557516003547	-4.17626517803884	24	4	0.0119047619047619	336	8202	56603,9249,220,157506	CYP26B1,DHRS3,ALDH1A3,RDH10
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.0154117874273699	-4.17262264498335	5	2	0.00595238095238095	336	8202	836,840	CASP3,CASP7
R-HSA-1614517	Sulfide oxidation to sulfate	0.0154117874273699	-4.17262264498335	5	2	0.00595238095238095	336	8202	6821,7263	SUOX,TST
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0154117874273699	-4.17262264498335	5	2	0.00595238095238095	336	8202	3038,57214	HAS3,CEMIP
R-HSA-70370	Galactose catabolism	0.0154117874273699	-4.17262264498335	5	2	0.00595238095238095	336	8202	5236,2582	PGM1,GALE
R-HSA-111463	SMAC binds to IAPs	0.0154117874273699	-4.17262264498335	5	2	0.00595238095238095	336	8202	836,840	CASP3,CASP7
R-HSA-111469	SMAC-mediated apoptotic response	0.0154117874273699	-4.17262264498335	5	2	0.00595238095238095	336	8202	836,840	CASP3,CASP7
R-HSA-5357801	Programmed Cell Death	0.0162039033212476	-4.12250312001054	163	13	0.0386904761904762	336	8202	836,2934,840,5721,581,8737,7431,5720,5588,317,2810,4000,355	CASP3,GSN,CASP7,PSME2,BAX,RIPK1,VIM,PSME1,PRKCQ,APAF1,SFN,LMNA,FAS
R-HSA-1236975	Antigen processing-Cross presentation	0.0174286363396795	-4.04964065890329	81	8	0.0238095238095238	336	8202	6892,10952,1535,5721,6890,5720,3685,3107	TAPBP,SEC61B,CYBA,PSME2,TAP1,PSME1,ITGAV,HLA-C
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.0185129940487527	-3.9892824124383	38	5	0.0148809523809524	336	8202	836,840,317,2810,581	CASP3,CASP7,APAF1,SFN,BAX
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-5654720	PI-3K cascade:FGFR4	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-5654689	PI-3K cascade:FGFR1	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-5654695	PI-3K cascade:FGFR2	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-5654710	PI-3K cascade:FGFR3	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-1257604	PIP3 activates AKT signaling	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2254,2261,4193,2263,5295,5290,1026,1956	IRS1,FGF9,FGFR3,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0186808918564473	-3.98025410339999	98	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-75153	Apoptotic execution  phase	0.0188158666109433	-3.97305479642034	52	6	0.0178571428571429	336	8202	836,2934,7431,5588,840,4000	CASP3,GSN,VIM,PRKCQ,CASP7,LMNA
R-HSA-381038	XBP1(S) activates chaperone genes	0.0205115608073838	-3.88676660996961	53	6	0.0178571428571429	336	8202	10952,6464,37,55062,4189,4000	SEC61B,SHC1,ACADVL,WIPI1,DNAJB9,LMNA
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.0214867019879464	-3.84032104739463	15	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.0214867019879464	-3.84032104739463	15	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-198203	PI3K/AKT activation	0.0223010150791767	-3.80312308230644	101	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.0224963717470693	-3.79440123846067	6	2	0.00595238095238095	336	8202	1384,51	CRAT,ACOX1
R-HSA-211916	Vitamins	0.0224963717470693	-3.79440123846067	6	2	0.00595238095238095	336	8202	56603,1591	CYP26B1,CYP24A1
R-HSA-5655253	Signaling by FGFR2 in disease	0.0230437691720871	-3.77035986399575	27	4	0.0119047619047619	336	8202	2254,2263,5295,5290	FGF9,FGFR2,PIK3R1,PIK3CA
R-HSA-180292	GAB1 signalosome	0.02361240473845	-3.74598308053215	102	9	0.0267857142857143	336	8202	3667,2261,2254,4193,2263,5295,5290,1026,1956	IRS1,FGFR3,FGF9,MDM2,FGFR2,PIK3R1,PIK3CA,CDKN1A,EGFR
R-HSA-446728	Cell junction organization	0.0241478054418316	-3.72356177498651	86	8	0.0238095238095238	336	8202	81607,1308,3909,25945,5818,87,3611,3691	PVRL4,COL17A1,LAMA3,PVRL3,PVRL1,ACTN1,ILK,ITGB4
R-HSA-381070	IRE1alpha activates chaperones	0.0242077087721124	-3.72108415224179	55	6	0.0178571428571429	336	8202	10952,6464,37,55062,4189,4000	SEC61B,SHC1,ACADVL,WIPI1,DNAJB9,LMNA
R-HSA-1980143	Signaling by NOTCH1	0.0274120657631626	-3.5967720061967	72	7	0.0208333333333333	336	8202	7088,182,54492,92737,3091,57534,23220	TLE1,JAG1,NEURL1B,DNER,HIF1A,MIB1,DTX4
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.0292630633267184	-3.53142919554414	29	4	0.0119047619047619	336	8202	847,2950,2876,475	CAT,GSTP1,GPX1,ATOX1
R-HSA-449147	Signaling by Interleukins	0.0302337232424293	-3.49879731394983	311	20	0.0595238095238095	336	8202	2254,3636,2335,5721,3635,1326,5295,5720,1956,3667,817,2261,6464,2905,2263,3656,6772,5290,7414,6774	FGF9,INPPL1,FN1,PSME2,INPP5D,MAP3K8,PIK3R1,PSME1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,IRAK2,STAT1,PIK3CA,VCL,STAT3
R-HSA-176412	Phosphorylation of the APC/C	0.0302349541184485	-3.49875660275609	17	3	0.00892857142857143	336	8202	51434,891,11065	ANAPC7,CCNB1,UBE2C
R-HSA-190371	FGFR3b ligand binding and activation	0.0306514232733345	-3.48507618135392	7	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-392499	Metabolism of proteins	0.0320509067882968	-3.44042980308912	943	50	0.148809523809524	336	8202	6209,3489,64924,7508,6235,136,84617,79642,23521,4189,4000,6164,4121,1912,6464,6134,6170,1471,5238,653604,5627,1363,6207,516,10484,6159,10678,10952,6133,7941,7039,6160,6612,6142,672,26503,10610,8869,29926,6189,2517,2934,6158,6210,55062,4905,6400,85365,8237,37	RPS15,IGFBP6,SLC30A5,XPC,RPS29,ADORA2B,TUBB6,ARSJ,RPL13A,DNAJB9,LMNA,RPL34,MAN1A1,PHC2,SHC1,RPL10,RPL39,CST3,PGM3,HIST2H3D,PROS1,CPE,RPS13,ATP5G1,SEC23A,RPL29,B3GNT2,SEC61B,RPL9,PLA2G7,TGFA,RPL31,SUMO3,RPL18A,BRCA1,SLC17A5,ST6GALNAC2,ST3GAL5,GMPPA,RPS3A,FUCA1,GSN,RPL28,RPS15A,WIPI1,NSF,SEL1L,ALG2,USP11,ACADVL
R-HSA-71387	Metabolism of carbohydrates	0.0322180869557978	-3.43522727742814	274	18	0.0535714285714286	336	8202	5236,10678,9060,375790,57214,6513,3074,5836,79586,2799,3038,51363,1462,4190,960,5631,6576,2582	PGM1,B3GNT2,PAPSS2,AGRN,CEMIP,SLC2A1,HEXB,PYGL,CHPF,GNS,HAS3,CHST15,VCAN,MDH1,CD44,PRPS1,SLC25A1,GALE
R-HSA-399719	Trafficking of AMPA receptors	0.0327101366305478	-3.42007026041373	30	4	0.0119047619047619	336	8202	817,4193,4905,160	CAMK2D,MDM2,NSF,AP2A1
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.0327101366305478	-3.42007026041373	30	4	0.0119047619047619	336	8202	817,4193,4905,160	CAMK2D,MDM2,NSF,AP2A1
R-HSA-5362517	Signaling by Retinoic Acid	0.0328677011096906	-3.41526483261127	44	5	0.0148809523809524	336	8202	56603,9249,1738,220,157506	CYP26B1,DHRS3,DLD,ALDH1A3,RDH10
R-HSA-912526	Interleukin receptor SHC signaling	0.0350645967912948	-3.35056329595301	238	16	0.0476190476190476	336	8202	2254,3636,2335,5721,3635,5295,5720,1956,3667,817,2261,6464,2905,2263,5290,7414	FGF9,INPPL1,FN1,PSME2,INPP5D,PIK3R1,PSME1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,PIK3CA,VCL
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.035209221532563	-3.34644725533073	18	3	0.00892857142857143	336	8202	2261,2254,6464	FGFR3,FGF9,SHC1
R-HSA-210993	Tie2 Signaling	0.035209221532563	-3.34644725533073	18	3	0.00892857142857143	336	8202	6464,5295,5290	SHC1,PIK3R1,PIK3CA
R-HSA-1483249	Inositol phosphate metabolism	0.0388517639355818	-3.24800179945192	46	5	0.0148809523809524	336	8202	51477,3636,3635,8821,5331	ISYNA1,INPPL1,INPP5D,INPP4B,PLCB3
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.039777882908963	-3.22444422695839	8	2	0.00595238095238095	336	8202	37,3032	ACADVL,HADHB
R-HSA-1614558	Degradation of cysteine and homocysteine	0.039777882908963	-3.22444422695839	8	2	0.00595238095238095	336	8202	6821,7263	SUOX,TST
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.039777882908963	-3.22444422695839	8	2	0.00595238095238095	336	8202	3685,1535	ITGAV,CYBA
R-HSA-3928664	Ephrin signaling	0.0405775738249036	-3.20453973383106	19	3	0.00892857142857143	336	8202	1948,6386,1947	EFNB2,SDCBP,EFNB1
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.0409656181413955	-3.19502214600152	1	1	0.00297619047619048	336	8202	2263	FGFR2
R-HSA-2033515	t(4;14) translocations of FGFR3	0.0409656181413955	-3.19502214600152	1	1	0.00297619047619048	336	8202	2261	FGFR3
R-HSA-1500931	Cell-Cell communication	0.0422360083167621	-3.1644821441262	131	10	0.0297619047619048	336	8202	81607,1308,3909,25945,5818,5295,5290,87,3691,3611	PVRL4,COL17A1,LAMA3,PVRL3,PVRL1,PIK3R1,PIK3CA,ACTN1,ITGB4,ILK
R-HSA-109704	PI3K Cascade	0.0424507181638748	-3.15941144849098	79	7	0.0208333333333333	336	8202	51719,3667,2261,2254,2263,5295,5290	CAB39,IRS1,FGFR3,FGF9,FGFR2,PIK3R1,PIK3CA
R-HSA-1483206	Glycerophospholipid biosynthesis	0.0426456805533877	-3.15482928676441	96	8	0.0238095238095238	336	8202	8760,84803,3032,10162,8694,8895,204962,1119	CDS2,GPAT3,HADHB,LPCAT3,DGAT1,CPNE3,SLC44A5,CHKA
R-HSA-2559583	Cellular Senescence	0.0432936255021849	-3.1397498718508	187	13	0.0386904761904762	336	8202	1912,3725,9134,1031,23043,4193,3397,23466,653604,51434,1026,6774,11065	PHC2,JUN,CCNE2,CDKN2C,TNIK,MDM2,ID1,CBX6,HIST2H3D,ANAPC7,CDKN1A,STAT3,UBE2C
R-HSA-451927	Interleukin-2 signaling	0.0438492008703201	-3.12699878449603	245	16	0.0476190476190476	336	8202	2254,3636,2335,5721,3635,5295,5720,1956,3667,817,2261,6464,2905,2263,5290,7414	FGF9,INPPL1,FN1,PSME2,INPP5D,PIK3R1,PSME1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,PIK3CA,VCL
R-HSA-186797	Signaling by PDGF	0.0445241453232281	-3.11172364542629	345	21	0.0625	336	8202	2254,1292,2335,5721,5295,5720,1026,9564,1956,3667,2261,817,4193,6464,2263,2905,1291,6772,5290,6774,7414	FGF9,COL6A2,FN1,PSME2,PIK3R1,PSME1,CDKN1A,BCAR1,EGFR,IRS1,FGFR3,CAMK2D,MDM2,SHC1,FGFR2,GRIN2C,COL6A1,STAT1,PIK3CA,STAT3,VCL
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.0454590881301727	-3.09094251948807	48	5	0.0148809523809524	336	8202	6209,6210,6235,6189,6207	RPS15,RPS15A,RPS29,RPS3A,RPS13
R-HSA-1236974	ER-Phagosome pathway	0.0462608739323874	-3.07345873060659	64	6	0.0178571428571429	336	8202	5720,6892,3107,10952,5721,6890	PSME1,TAPBP,HLA-C,SEC61B,PSME2,TAP1
R-HSA-3000170	Syndecan interactions	0.0463333353707283	-3.071893590547	20	3	0.00892857142857143	336	8202	87,3685,3691	ACTN1,ITGAV,ITGB4
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.0470770347911242	-3.05596998092009	267	17	0.0505952380952381	336	8202	10484,10952,9903,5721,6890,79654,65264,9666,5720,6892,1535,51434,3107,3685,64219,11065,64167	SEC23A,SEC61B,KLHL21,PSME2,TAP1,HECTD3,UBE2Z,DZIP3,PSME1,TAPBP,CYBA,ANAPC7,HLA-C,ITGAV,PJA1,UBE2C,ERAP2
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.0524683434342555	-2.9475452734561	21	3	0.00892857142857143	336	8202	1462,51363,79586	VCAN,CHST15,CHPF
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.0524683434342555	-2.9475452734561	21	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.0524683434342555	-2.9475452734561	21	3	0.00892857142857143	336	8202	1326,5295,5290	MAP3K8,PIK3R1,PIK3CA
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.0524683434342555	-2.9475452734561	21	3	0.00892857142857143	336	8202	51434,891,11065	ANAPC7,CCNB1,UBE2C
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.054018029738918	-2.9184374040907	312	19	0.056547619047619	336	8202	2254,2335,5721,5295,5720,26999,9564,1956,3667,2261,817,6464,1535,2263,2905,5290,3685,7414,9475	FGF9,FN1,PSME2,PIK3R1,PSME1,CYFIP2,BCAR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,CYBA,FGFR2,GRIN2C,PIK3CA,ITGAV,VCL,ROCK2
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.055703722521229	-2.88770830266212	67	6	0.0178571428571429	336	8202	26503,85365,10610,8869,29926,5238	SLC17A5,ALG2,ST6GALNAC2,ST3GAL5,GMPPA,PGM3
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0565532394802746	-2.87257279282158	51	5	0.0148809523809524	336	8202	375790,1462,51363,3074,79586	AGRN,VCAN,CHST15,HEXB,CHPF
R-HSA-1483255	PI Metabolism	0.0565532394802746	-2.87257279282158	51	5	0.0148809523809524	336	8202	3636,3635,5295,8821,5290	INPPL1,INPP5D,PIK3R1,INPP4B,PIK3CA
R-HSA-397795	G-protein beta:gamma signalling	0.0565532394802746	-2.87257279282158	51	5	0.0148809523809524	336	8202	54331,6464,5295,5331,5290	GNG2,SHC1,PIK3R1,PLCB3,PIK3CA
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.0573184904015468	-2.85913201269928	254	16	0.0476190476190476	336	8202	2254,3636,2335,5721,3635,5295,5720,1956,3667,817,2261,6464,2905,2263,5290,7414	FGF9,INPPL1,FN1,PSME2,INPP5D,PIK3R1,PSME1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,PIK3CA,VCL
R-HSA-373753	Nephrin interactions	0.0589731357239823	-2.83067326548127	22	3	0.00892857142857143	336	8202	87,5295,5290	ACTN1,PIK3R1,PIK3CA
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.0590912769347688	-2.82867196386027	68	6	0.0178571428571429	336	8202	6118,10808,3337,3306,3303,3304	RPA2,HSPH1,DNAJB1,HSPA2,HSPA1A,HSPA1B
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.0605678536149527	-2.80399099505513	52	5	0.0148809523809524	336	8202	26503,10610,8869,29926,5238	SLC17A5,ST6GALNAC2,ST3GAL5,GMPPA,PGM3
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.0605798363324367	-2.80379317506321	10	2	0.00595238095238095	336	8202	134353,6628	LSM11,SNRPB
R-HSA-74749	Signal attenuation	0.0605798363324367	-2.80379317506321	10	2	0.00595238095238095	336	8202	3667,6464	IRS1,SHC1
R-HSA-3371556	Cellular response to heat stress	0.0620165994555279	-2.78035319661749	86	7	0.0208333333333333	336	8202	6118,10808,817,3337,3306,3303,3304	RPA2,HSPH1,CAMK2D,DNAJB1,HSPA2,HSPA1A,HSPA1B
R-HSA-156590	Glutathione conjugation	0.0632184475755021	-2.76115912840407	37	4	0.0119047619047619	336	8202	373156,2941,2950,2937	GSTK1,GSTA4,GSTP1,GSS
R-HSA-194138	Signaling by VEGF	0.0661149539448302	-2.71636032556544	320	19	0.056547619047619	336	8202	2254,2335,5721,5295,5720,26999,9564,1956,3667,2261,817,6464,1535,2263,2905,5290,3685,7414,9475	FGF9,FN1,PSME2,PIK3R1,PSME1,CYFIP2,BCAR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,CYBA,FGFR2,GRIN2C,PIK3CA,ITGAV,VCL,ROCK2
R-HSA-446203	Asparagine N-linked glycosylation	0.0679458054082334	-2.68904487085355	181	12	0.0357142857142857	336	8202	2517,10484,4905,7039,6400,5238,85365,26503,10610,8869,29926,4121	FUCA1,SEC23A,NSF,TGFA,SEL1L,PGM3,ALG2,SLC17A5,ST6GALNAC2,ST3GAL5,GMPPA,MAN1A1
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.0690702122492462	-2.67263172292744	54	5	0.0148809523809524	336	8202	7108,10484,4047,85441,3156	TM7SF2,SEC23A,LSS,HELZ2,HMGCR
R-HSA-186763	Downstream signal transduction	0.0694087525809565	-2.66774230154035	322	19	0.056547619047619	336	8202	2254,2335,5721,5295,5720,1026,9564,1956,3667,817,2261,4193,6464,2263,2905,6772,5290,6774,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,BCAR1,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,STAT1,PIK3CA,STAT3,VCL
R-HSA-1474228	Degradation of the extracellular matrix	0.0718454720456819	-2.63323768798805	89	7	0.0208333333333333	336	8202	836,1308,3909,960,4325,823,3912	CASP3,COL17A1,LAMA3,CD44,MMP16,CAPN1,LAMB1
R-HSA-3371378	Regulation by c-FLIP	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-5218900	CASP8 activity is inhibited	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-1059683	Interleukin-6 signaling	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	6774,6772	STAT3,STAT1
R-HSA-5655291	Signaling by FGFR4 in disease	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	5295,5290	PIK3R1,PIK3CA
R-HSA-69416	Dimerization of procaspase-8	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	51477,8821	ISYNA1,INPP4B
R-HSA-189451	Heme biosynthesis	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	7390,1371	UROS,CPOX
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.072087238690575	-2.62987824493949	11	2	0.00595238095238095	336	8202	134353,6628	LSM11,SNRPB
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.0730487474436877	-2.61662828749386	24	3	0.00892857142857143	336	8202	8541,10550,6505	PPFIA3,ARL6IP5,SLC1A1
R-HSA-72702	Ribosomal scanning and start codon recognition	0.0735564625973177	-2.60970196907391	55	5	0.0148809523809524	336	8202	6209,6210,6235,6189,6207	RPS15,RPS15A,RPS29,RPS3A,RPS13
R-HSA-72649	Translation initiation complex formation	0.0735564625973177	-2.60970196907391	55	5	0.0148809523809524	336	8202	6209,6210,6235,6189,6207	RPS15,RPS15A,RPS29,RPS3A,RPS13
R-HSA-109582	Hemostasis	0.0748661261939677	-2.59205374450864	515	28	0.0833333333333333	336	8202	3920,2335,967,3635,1609,5295,9123,5588,87,9564,5139,965,2152,3833,54331,6464,3675,6281,10846,5290,653604,5627,3685,50808,960,2149,7414,3659	LAMP2,FN1,CD63,INPP5D,DGKQ,PIK3R1,SLC16A3,PRKCQ,ACTN1,BCAR1,PDE3A,CD58,F3,KIFC1,GNG2,SHC1,ITGA3,S100A10,PDE10A,PIK3CA,HIST2H3D,PROS1,ITGAV,AK3,CD44,F2R,VCL,IRF1
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.0781980106695582	-2.54851107076266	56	5	0.0148809523809524	336	8202	6209,6210,6235,6189,6207	RPS15,RPS15A,RPS29,RPS3A,RPS13
R-HSA-1433557	Signaling by SCF-KIT	0.0793820193777444	-2.53348339257382	307	18	0.0535714285714286	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,6772,5290,6774,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,STAT1,PIK3CA,STAT3,VCL
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.0802578449781976	-2.52251076501223	2	1	0.00297619047619048	336	8202	1026	CDKN1A
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.0802578449781976	-2.52251076501223	2	1	0.00297619047619048	336	8202	1956	EGFR
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.0802578449781976	-2.52251076501223	2	1	0.00297619047619048	336	8202	1026	CDKN1A
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.0802578449781976	-2.52251076501223	2	1	0.00297619047619048	336	8202	581	BAX
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.0802578449781976	-2.52251076501223	2	1	0.00297619047619048	336	8202	836	CASP3
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.0802578449781976	-2.52251076501223	2	1	0.00297619047619048	336	8202	1956	EGFR
R-HSA-425410	Metal ion SLC transporters	0.0805956285289711	-2.51831086755367	25	3	0.00892857142857143	336	8202	30061,64924,27173	SLC40A1,SLC30A5,SLC39A1
R-HSA-982772	Growth hormone receptor signaling	0.0805956285289711	-2.51831086755367	25	3	0.00892857142857143	336	8202	3667,6774,6772	IRS1,STAT3,STAT1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.0829934909856834	-2.48899309611993	57	5	0.0148809523809524	336	8202	9134,5720,4193,1026,5721	CCNE2,PSME1,MDM2,CDKN1A,PSME2
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.0829934909856834	-2.48899309611993	57	5	0.0148809523809524	336	8202	9134,5720,4193,1026,5721	CCNE2,PSME1,MDM2,CDKN1A,PSME2
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0838169251151652	-2.47912032153933	168	11	0.0327380952380952	336	8202	3667,2254,2261,4193,2263,5721,5295,5290,5720,1026,1956	IRS1,FGF9,FGFR3,MDM2,FGFR2,PSME2,PIK3R1,PIK3CA,PSME1,CDKN1A,EGFR
R-HSA-2160916	Hyaluronan uptake and degradation	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	960,3074	CD44,HEXB
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	891,2810	CCNB1,SFN
R-HSA-2022857	Keratan sulfate degradation	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	2799,3074	GNS,HEXB
R-HSA-210990	PECAM1 interactions	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	3685,3635	ITGAV,INPP5D
R-HSA-73621	Pyrimidine catabolism	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	1890,4907	TYMP,NT5E
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-190239	FGFR3 ligand binding and activation	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-2033514	FGFR3 mutant receptor activation	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-190372	FGFR3c ligand binding and activation	0.0842292270165753	-2.47421330375295	12	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.0855536264469396	-2.45861188974762	41	4	0.0119047619047619	336	8202	7108,4047,85441,3156	TM7SF2,LSS,HELZ2,HMGCR
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0884646959580258	-2.42515172228482	26	3	0.00892857142857143	336	8202	8737,23220,1660	RIPK1,DTX4,DHX9
R-HSA-912694	Regulation of IFNA signaling	0.0884646959580258	-2.42515172228482	26	3	0.00892857142857143	336	8202	11274,6773,6772	USP18,STAT2,STAT1
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.0884646959580258	-2.42515172228482	26	3	0.00892857142857143	336	8202	2254,6464,2263	FGF9,SHC1,FGFR2
R-HSA-76002	Platelet activation, signaling and aggregation	0.0896092718084397	-2.41229648435003	230	14	0.0416666666666667	336	8202	3920,54331,2335,6464,967,1609,5295,5290,5588,87,5627,2149,7414,9564	LAMP2,GNG2,FN1,SHC1,CD63,DGKQ,PIK3R1,PIK3CA,PRKCQ,ACTN1,PROS1,F2R,VCL,BCAR1
R-HSA-3928662	EPHB-mediated forward signaling	0.0916650581448975	-2.38961401764784	42	4	0.0119047619047619	336	8202	1948,7074,9475,1947	EFNB2,TIAM1,ROCK2,EFNB1
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.0916650581448975	-2.38961401764784	42	4	0.0119047619047619	336	8202	1408,85441,8204,3091	CRY2,HELZ2,NRIP1,HIF1A
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.0951725878752386	-2.3520633211352	212	13	0.0386904761904762	336	8202	123,85441,5468,27242,51,84803,3032,51495,8694,37,51129,6576,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ACOX1,GPAT3,HADHB,HACD3,DGAT1,ACADVL,ANGPTL4,SLC25A1,HMGCR
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.0966423118055039	-2.33673862325328	27	3	0.00892857142857143	336	8202	2335,6464,9564	FN1,SHC1,BCAR1
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.0966423118055039	-2.33673862325328	27	3	0.00892857142857143	336	8202	8737,836,355	RIPK1,CASP3,FAS
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0966423118055039	-2.33673862325328	27	3	0.00892857142857143	336	8202	3636,3635,5331	INPPL1,INPP5D,PLCB3
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.096934849431254	-2.33371618148815	13	2	0.00595238095238095	336	8202	4193,1026	MDM2,CDKN1A
R-HSA-190375	FGFR2c ligand binding and activation	0.096934849431254	-2.33371618148815	13	2	0.00595238095238095	336	8202	2254,2263	FGF9,FGFR2
R-HSA-917937	Iron uptake and transport	0.0979788215538582	-2.32300393025924	43	4	0.0119047619047619	336	8202	2495,30061,10312,523	FTH1,SLC40A1,TCIRG1,ATP6V1A
R-HSA-69615	G1/S DNA Damage Checkpoints	0.0982864367415246	-2.31986923956328	60	5	0.0148809523809524	336	8202	9134,5720,4193,1026,5721	CCNE2,PSME1,MDM2,CDKN1A,PSME2
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.104489933597165	-2.25866454143096	44	4	0.0119047619047619	336	8202	6118,6612,1643,7508	RPA2,SUMO3,DDB2,XPC
R-HSA-1280218	Adaptive Immune System	0.107979694257142	-2.22581208567274	668	34	0.101190476190476	336	8202	9903,5721,3635,1326,6890,79654,65264,9666,5720,1026,6494,2261,4193,6464,5290,51434,64219,3107,79659,64167,2254,10484,10952,5295,5588,1956,3667,6892,1535,2263,160,1174,3685,11065	KLHL21,PSME2,INPP5D,MAP3K8,TAP1,HECTD3,UBE2Z,DZIP3,PSME1,CDKN1A,SIPA1,FGFR3,MDM2,SHC1,PIK3CA,ANAPC7,PJA1,HLA-C,DYNC2H1,ERAP2,FGF9,SEC23A,SEC61B,PIK3R1,PRKCQ,EGFR,IRS1,TAPBP,CYBA,FGFR2,AP2A1,AP1S1,ITGAV,UBE2C
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.11013787210985	-2.20602231520142	14	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-2024101	CS/DS degradation	0.11013787210985	-2.20602231520142	14	2	0.00595238095238095	336	8202	1462,3074	VCAN,HEXB
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.11013787210985	-2.20602231520142	14	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-5675482	Regulation of necroptotic cell death	0.11013787210985	-2.20602231520142	14	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-422475	Axon guidance	0.111699474568492	-2.19194327687067	516	27	0.0803571428571429	336	8202	1948,2254,1292,2335,375790,5721,5588,5720,214,1947,1956,3667,2261,817,6464,2905,2263,160,3912,1291,6386,3685,7414,10371,7074,9475,9353	EFNB2,FGF9,COL6A2,FN1,AGRN,PSME2,PRKCQ,PSME1,ALCAM,EFNB1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,GRIN2C,FGFR2,AP2A1,LAMB1,COL6A1,SDCBP,ITGAV,VCL,SEMA3A,TIAM1,ROCK2,SLIT2
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.112884962017859	-2.18138601405982	198	12	0.0357142857142857	336	8202	3667,2254,2261,4193,6464,2263,5721,5295,5290,5720,1026,1956	IRS1,FGF9,FGFR3,MDM2,SHC1,FGFR2,PSME2,PIK3R1,PIK3CA,PSME1,CDKN1A,EGFR
R-HSA-1280215	Cytokine Signaling in Immune system	0.113749475302909	-2.1737568338834	539	28	0.0833333333333333	336	8202	2254,3636,2335,10410,5721,11274,3635,1326,5295,5720,1956,9636,6773,3667,817,2261,6464,2905,2263,3656,6772,5290,4940,3107,960,7414,6774,3659	FGF9,INPPL1,FN1,IFITM3,PSME2,USP18,INPP5D,MAP3K8,PIK3R1,PSME1,EGFR,ISG15,STAT2,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,IRAK2,STAT1,PIK3CA,OAS3,HLA-C,CD44,VCL,STAT3,IRF1
R-HSA-114608	Platelet degranulation	0.113982728847243	-2.1717083434051	81	6	0.0178571428571429	336	8202	3920,87,5627,2335,967,7414	LAMP2,ACTN1,PROS1,FN1,CD63,VCL
R-HSA-69620	Cell Cycle Checkpoints	0.116874216343395	-2.14665699647901	179	11	0.0327380952380952	336	8202	9134,6118,4193,5721,5720,51434,1026,672,891,11065,2810	CCNE2,RPA2,MDM2,PSME2,PSME1,ANAPC7,CDKN1A,BRCA1,CCNB1,UBE2C,SFN
R-HSA-5653890	Lactose synthesis	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	6513	SLC2A1
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	4595	MUTYH
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	4121	MAN1A1
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-111458	Formation of apoptosome	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	5631	PRPS1
R-HSA-198745	Signalling to STAT3	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	6774	STAT3
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-110331	Cleavage of the damaged purine	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	4595	MUTYH
R-HSA-352238	Breakdown of the nuclear lamina	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	4000	LMNA
R-HSA-351200	Interconversion of polyamines	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	6303	SAT1
R-HSA-73927	Depurination	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	4595	MUTYH
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.117944840598832	-2.13753821635875	3	1	0.00297619047619048	336	8202	3091	HIF1A
R-HSA-74752	Signaling by Insulin receptor	0.118914024702182	-2.12935452848041	304	17	0.0505952380952381	336	8202	2254,2335,523,5721,5295,5720,1956,3667,817,2261,10312,6464,2263,2905,5290,51719,7414	FGF9,FN1,ATP6V1A,PSME2,PIK3R1,PSME1,EGFR,IRS1,CAMK2D,FGFR3,TCIRG1,SHC1,FGFR2,GRIN2C,PIK3CA,CAB39,VCL
R-HSA-5656169	Termination of translesion DNA synthesis	0.12288382599545	-2.09651587403681	30	3	0.00892857142857143	336	8202	6118,5429,9636	RPA2,POLH,ISG15
R-HSA-2559585	Oncogene Induced Senescence	0.12288382599545	-2.09651587403681	30	3	0.00892857142857143	336	8202	1031,4193,3397	CDKN2C,MDM2,ID1
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.123776513669104	-2.08927764861044	15	2	0.00595238095238095	336	8202	891,4000	CCNB1,LMNA
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.123776513669104	-2.08927764861044	15	2	0.00595238095238095	336	8202	2335,9564	FN1,BCAR1
R-HSA-5358508	Mismatch Repair	0.123776513669104	-2.08927764861044	15	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-351202	Metabolism of polyamines	0.129398830459464	-2.04485593513652	84	6	0.0178571428571429	336	8202	51582,5720,1728,5721,548596,6303	AZIN1,PSME1,NQO1,PSME2,CKMT1A,SAT1
R-HSA-375165	NCAM signaling for neurite out-growth	0.130287545831929	-2.03801138014143	266	15	0.0446428571428571	336	8202	3667,2261,2254,817,1292,6464,2335,375790,2905,2263,5721,1291,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,COL6A2,SHC1,FN1,AGRN,GRIN2C,FGFR2,PSME2,COL6A1,PSME1,VCL,EGFR
R-HSA-418990	Adherens junctions interactions	0.13215159858454	-2.02380554126236	31	3	0.00892857142857143	336	8202	81607,25945,5818	PVRL4,PVRL3,PVRL1
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.132397966241428	-2.02194299631149	48	4	0.0119047619047619	336	8202	1948,7074,160,1947	EFNB2,TIAM1,AP2A1,EFNB1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.132397966241428	-2.02194299631149	48	4	0.0119047619047619	336	8202	54331,6464,5295,5290	GNG2,SHC1,PIK3R1,PIK3CA
R-HSA-5218859	Regulated Necrosis	0.137793193266578	-1.98200131736586	16	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-446353	Cell-extracellular matrix interactions	0.137793193266578	-1.98200131736586	16	2	0.00595238095238095	336	8202	87,3611	ACTN1,ILK
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.137793193266578	-1.98200131736586	16	2	0.00595238095238095	336	8202	4905,160	NSF,AP2A1
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.137793193266578	-1.98200131736586	16	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-69183	Processive synthesis on the lagging strand	0.137793193266578	-1.98200131736586	16	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.138760307720947	-1.97500723923425	105	7	0.0208333333333333	336	8202	3725,1031,653604,51434,1026,11065,6774	JUN,CDKN2C,HIST2H3D,ANAPC7,CDKN1A,UBE2C,STAT3
R-HSA-216083	Integrin cell surface interactions	0.138959780408651	-1.97357073729916	67	5	0.0148809523809524	336	8202	3685,3675,2335,960,375790	ITGAV,ITGA3,FN1,CD44,AGRN
R-HSA-381119	Unfolded Protein Response (UPR)	0.140205618125176	-1.964645232965	86	6	0.0178571428571429	336	8202	10952,6464,37,55062,4189,4000	SEC61B,SHC1,ACADVL,WIPI1,DNAJB9,LMNA
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.140205618125176	-1.964645232965	86	6	0.0178571428571429	336	8202	3920,87,5627,2335,967,7414	LAMP2,ACTN1,PROS1,FN1,CD63,VCL
R-HSA-1980145	Signaling by NOTCH2	0.141654782037308	-1.95436229374628	32	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-389356	CD28 co-stimulation	0.141654782037308	-1.95436229374628	32	3	0.00892857142857143	336	8202	1326,5295,5290	MAP3K8,PIK3R1,PIK3CA
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.147386373860209	-1.91469774678221	50	4	0.0119047619047619	336	8202	51582,5720,1728,5721	AZIN1,PSME1,NQO1,PSME2
R-HSA-418555	G alpha (s) signalling events	0.149476234201316	-1.90061786734131	127	8	0.0238095238095238	336	8202	54331,7433,10846,5142,5734,136,5139,133	GNG2,VIPR1,PDE10A,PDE4B,PTGER4,ADORA2B,PDE3A,ADM
R-HSA-73847	Purine metabolism	0.151378349394935	-1.88797295088011	33	3	0.00892857142857143	336	8202	847,2876,4907	CAT,GPX1,NT5E
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.151378349394935	-1.88797295088011	33	3	0.00892857142857143	336	8202	2799,10678,3074	GNS,B3GNT2,HEXB
R-HSA-4085001	Sialic acid metabolism	0.151378349394935	-1.88797295088011	33	3	0.00892857142857143	336	8202	26503,10610,8869	SLC17A5,ST6GALNAC2,ST3GAL5
R-HSA-2033519	Activated point mutants of FGFR2	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	2254,2263	FGF9,FGFR2
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	51434,11065	ANAPC7,UBE2C
R-HSA-1839126	FGFR2 mutant receptor activation	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	2254,2263	FGF9,FGFR2
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	817,2905	CAMK2D,GRIN2C
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	817,2905	CAMK2D,GRIN2C
R-HSA-140534	Ligand-dependent caspase activation	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-435354	Zinc transporters	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	64924,27173	SLC30A5,SLC39A1
R-HSA-189445	Metabolism of porphyrins	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	7390,1371	UROS,CPOX
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	37,3032	ACADVL,HADHB
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.152134291820545	-1.88299164937184	17	2	0.00595238095238095	336	8202	5836,5236	PYGL,PGM1
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	3611	ILK
R-HSA-71262	Carnitine synthesis	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	223	ALDH9A1
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	9353	SLIT2
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	9134	CCNE2
R-HSA-6783984	Glycine degradation	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	1738	DLD
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-417973	Adenosine P1 receptors	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	136	ADORA2B
R-HSA-433692	Proton-coupled monocarboxylate transport	0.154091996784923	-1.87020547320966	4	1	0.00297619047619048	336	8202	9123	SLC16A3
R-HSA-1222556	ROS production in response to bacteria	0.1613073012409	-1.82444402989772	34	3	0.00892857142857143	336	8202	10312,1535,523	TCIRG1,CYBA,ATP6V1A
R-HSA-112399	IRS-mediated signalling	0.164262008775817	-1.80629251149966	277	15	0.0446428571428571	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5295,5290,51719,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PIK3R1,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.16437747343449	-1.80558982865312	342	18	0.0535714285714286	336	8202	2254,2335,5721,5295,5588,5720,1026,1956,3667,3725,817,2261,4193,6464,2905,2263,5290,7414	FGF9,FN1,PSME2,PIK3R1,PRKCQ,PSME1,CDKN1A,EGFR,IRS1,JUN,CAMK2D,FGFR3,MDM2,SHC1,GRIN2C,FGFR2,PIK3CA,VCL
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	51434,11065	ANAPC7,UBE2C
R-HSA-912631	Regulation of signaling by CBL	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	5295,5290	PIK3R1,PIK3CA
R-HSA-156584	Cytosolic sulfonation of small molecules	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	6819,9060	SULT1C2,PAPSS2
R-HSA-418457	cGMP effects	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	10846,5139	PDE10A,PDE3A
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	5986,6400	RFNG,SEL1L
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	112399,3091	EGLN3,HIF1A
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.166749925604885	-1.79126004033412	18	2	0.00595238095238095	336	8202	51434,11065	ANAPC7,UBE2C
R-HSA-2586552	Signaling by Leptin	0.170639676836012	-1.76820109865574	236	13	0.0386904761904762	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,6774,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,STAT3,EGFR
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.171426721087426	-1.76359938597629	35	3	0.00892857142857143	336	8202	3978,6118,4595	LIG1,RPA2,MUTYH
R-HSA-73884	Base Excision Repair	0.171426721087426	-1.76359938597629	35	3	0.00892857142857143	336	8202	3978,6118,4595	LIG1,RPA2,MUTYH
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.171837748099604	-1.76120457238202	72	5	0.0148809523809524	336	8202	51434,5720,891,11065,5721	ANAPC7,PSME1,CCNB1,UBE2C,PSME2
R-HSA-211859	Biological oxidations	0.172197253503398	-1.75911463657332	194	11	0.0327380952380952	336	8202	56603,1591,373156,6819,9060,8824,2232,2941,66002,2950,2937	CYP26B1,CYP24A1,GSTK1,SULT1C2,PAPSS2,CES2,FDXR,GSTA4,CYP4F12,GSTP1,GSS
R-HSA-74751	Insulin receptor signalling cascade	0.174266783936364	-1.74716791296794	280	15	0.0446428571428571	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5295,5290,51719,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PIK3R1,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-877300	Interferon gamma signaling	0.174983219345245	-1.74306519911205	92	6	0.0178571428571429	336	8202	817,3107,4940,960,6772,3659	CAMK2D,HLA-C,OAS3,CD44,STAT1,IRF1
R-HSA-1989781	PPARA activates gene expression	0.175134550587506	-1.74220073998041	112	7	0.0208333333333333	336	8202	123,85441,5468,27242,51129,51,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ANGPTL4,ACOX1,HMGCR
R-HSA-2428924	IGF1R signaling cascade	0.177669361759098	-1.72783097422367	281	15	0.0446428571428571	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5295,5290,51719,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PIK3R1,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-2428928	IRS-related events triggered by IGF1R	0.177669361759098	-1.72783097422367	281	15	0.0446428571428571	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5295,5290,51719,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PIK3R1,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.177669361759098	-1.72783097422367	281	15	0.0446428571428571	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5295,5290,51719,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PIK3R1,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.178749616261033	-1.72176924420175	73	5	0.0148809523809524	336	8202	51434,5720,891,11065,5721	ANAPC7,PSME1,CCNB1,UBE2C,PSME2
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.179172524999948	-1.71940611050886	54	4	0.0119047619047619	336	8202	1292,3909,3691,1291	COL6A2,LAMA3,ITGB4,COL6A1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-69618	Mitotic Spindle Checkpoint	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	51434,11065	ANAPC7,UBE2C
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-110320	Translesion Synthesis by POLH	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	6118,5429	RPA2,POLH
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-71403	Citric acid cycle (TCA cycle)	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	1738,6389	DLD,SDHA
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.181593731695406	-1.70598333050645	19	2	0.00595238095238095	336	8202	817,2905	CAMK2D,GRIN2C
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.187456137737135	-1.67421039300666	55	4	0.0119047619047619	336	8202	5720,5721,3303,3304	PSME1,PSME2,HSPA1A,HSPA1B
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	2152	F3
R-HSA-75157	FasL/ CD95L signaling	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	355	FAS
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-446205	Synthesis of GDP-mannose	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	29926	GMPPA
R-HSA-74713	IRS activation	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	3667	IRS1
R-HSA-2161517	Abacavir transmembrane transport	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	5243	ABCB1
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-197264	Nicotinamide salvaging	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	93100	NAPRT
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	60489	APOBEC3G
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	4121	MAN1A1
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	113278	SLC52A3
R-HSA-69478	G2/M DNA replication checkpoint	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	6612	SUMO3
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.188762049124551	-1.667268056469	5	1	0.00297619047619048	336	8202	5238	PGM3
R-HSA-453279	Mitotic G1-G1/S phases	0.188823171758908	-1.66694430102779	135	8	0.0238095238095238	336	8202	7153,9134,6118,1031,5721,5720,1026,891	TOP2A,CCNE2,RPA2,CDKN2C,PSME2,PSME1,CDKN1A,CCNB1
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.191867885786474	-1.6509482386624	115	7	0.0208333333333333	336	8202	123,85441,5468,27242,51129,51,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ANGPTL4,ACOX1,HMGCR
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.192178005265957	-1.6493332256959	37	3	0.00892857142857143	336	8202	2335,6464,9564	FN1,SHC1,BCAR1
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.192178005265957	-1.6493332256959	37	3	0.00892857142857143	336	8202	6118,5429,9636	RPA2,POLH,ISG15
R-HSA-419037	NCAM1 interactions	0.192178005265957	-1.6493332256959	37	3	0.00892857142857143	336	8202	1292,375790,1291	COL6A2,AGRN,COL6A1
R-HSA-416482	G alpha (12/13) signalling events	0.192878072428831	-1.6456970387882	75	5	0.0148809523809524	336	8202	54331,7074,9475,5295,5290	GNG2,TIAM1,ROCK2,PIK3R1,PIK3CA
R-HSA-2682334	EPH-Ephrin signaling	0.193580201500618	-1.64206337434523	95	6	0.0178571428571429	336	8202	1948,6386,7074,160,9475,1947	EFNB2,SDCBP,TIAM1,AP2A1,ROCK2,EFNB1
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.195860609050547	-1.63035205107241	56	4	0.0119047619047619	336	8202	9134,5720,1026,5721	CCNE2,PSME1,CDKN1A,PSME2
R-HSA-1483191	Synthesis of PC	0.196622664618686	-1.62646879501086	20	2	0.00595238095238095	336	8202	204962,1119	SLC44A5,CHKA
R-HSA-190241	FGFR2 ligand binding and activation	0.196622664618686	-1.62646879501086	20	2	0.00595238095238095	336	8202	2254,2263	FGF9,FGFR2
R-HSA-2028269	Signaling by Hippo	0.196622664618686	-1.62646879501086	20	2	0.00595238095238095	336	8202	836,154796	CASP3,AMOT
R-HSA-418217	G beta:gamma signalling through PLC beta	0.196622664618686	-1.62646879501086	20	2	0.00595238095238095	336	8202	54331,5331	GNG2,PLCB3
R-HSA-202424	Downstream TCR signaling	0.199940953785847	-1.60973318709414	96	6	0.0178571428571429	336	8202	5588,5720,5721,3635,5295,5290	PRKCQ,PSME1,PSME2,INPP5D,PIK3R1,PIK3CA
R-HSA-5654716	Downstream signaling of activated FGFR4	0.202483567835007	-1.59709654222189	310	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-5654687	Downstream signaling of activated FGFR1	0.202483567835007	-1.59709654222189	310	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-5654708	Downstream signaling of activated FGFR3	0.202483567835007	-1.59709654222189	310	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-5654696	Downstream signaling of activated FGFR2	0.202483567835007	-1.59709654222189	310	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.205100083163193	-1.58425720842757	355	18	0.0535714285714286	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,160,5290,6774,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,AP2A1,PIK3CA,STAT3,VCL
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.206378019985891	-1.57804574336186	97	6	0.0178571428571429	336	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.206378019985891	-1.57804574336186	97	6	0.0178571428571429	336	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-373760	L1CAM interactions	0.206378019985891	-1.57804574336186	97	6	0.0178571428571429	336	8202	6386,3685,214,160,3912,1956	SDCBP,ITGAV,ALCAM,AP2A1,LAMB1,EGFR
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.206378019985891	-1.57804574336186	97	6	0.0178571428571429	336	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.207385351899266	-1.57317661297473	77	5	0.0148809523809524	336	8202	51434,5720,891,11065,5721	ANAPC7,PSME1,CCNB1,UBE2C,PSME2
R-HSA-1236394	Signaling by ERBB4	0.209564320971545	-1.56272456539746	312	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.211477326678222	-1.55363748870944	424	21	0.0625	336	8202	2254,2335,5721,1609,5295,5588,5720,5997,1956,5331,301,54331,3667,2261,817,6464,2263,2905,5290,7414,2149	FGF9,FN1,PSME2,DGKQ,PIK3R1,PRKCQ,PSME1,RGS2,EGFR,PLCB3,ANXA1,GNG2,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,PIK3CA,VCL,F2R
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	1174,160	AP1S1,AP2A1
R-HSA-500657	Presynaptic function of Kainate receptors	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	54331,5331	GNG2,PLCB3
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	2254,6464	FGF9,SHC1
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	8737,1660	RIPK1,DHX9
R-HSA-390918	Peroxisomal lipid metabolism	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	1384,51	CRAT,ACOX1
R-HSA-69186	Lagging Strand Synthesis	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-445144	Signal transduction by L1	0.211796803698881	-1.55212793705769	21	2	0.00595238095238095	336	8202	3685,1956	ITGAV,EGFR
R-HSA-156580	Phase II conjugation	0.212888593710288	-1.54698628432682	98	6	0.0178571428571429	336	8202	373156,2941,6819,9060,2950,2937	GSTK1,GSTA4,SULT1C2,PAPSS2,GSTP1,GSS
R-HSA-5654741	Signaling by FGFR3	0.213147000097965	-1.54577321000571	313	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-5654743	Signaling by FGFR4	0.213147000097965	-1.54577321000571	313	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-6783310	Fanconi Anemia Pathway	0.213516278452984	-1.54404220353859	39	3	0.00892857142857143	336	8202	6118,2189,197342	RPA2,FANCG,EME2
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.213516278452984	-1.54404220353859	39	3	0.00892857142857143	336	8202	5627,2149,2152	PROS1,F2R,F3
R-HSA-2559580	Oxidative Stress Induced Senescence	0.215128253955436	-1.5365208986825	119	7	0.0208333333333333	336	8202	1912,3725,1031,653604,23043,4193,23466	PHC2,JUN,CDKN2C,HIST2H3D,TNIK,MDM2,CBX6
R-HSA-177929	Signaling by EGFR	0.216046647714821	-1.53226093297164	336	17	0.0505952380952381	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,160,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,AP2A1,PIK3CA,VCL
R-HSA-5654736	Signaling by FGFR1	0.216757376949723	-1.52897662953052	314	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-2871796	FCERI mediated MAPK activation	0.217114429717314	-1.52733073854288	248	13	0.0386904761904762	336	8202	3725,3667,2254,2261,817,2335,6464,2263,2905,5721,5720,7414,1956	JUN,IRS1,FGF9,FGFR3,CAMK2D,FN1,SHC1,FGFR2,GRIN2C,PSME2,PSME1,VCL,EGFR
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	8694	DGAT1
R-HSA-176417	Phosphorylation of Emi1	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-1482798	Acyl chain remodeling of CL	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-1566977	Fibronectin matrix formation	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	2335	FN1
R-HSA-174362	Transport and synthesis of PAPS	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	9060	PAPSS2
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	2517	FUCA1
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	2876	GPX1
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	6612	SUMO3
R-HSA-205025	NADE modulates death signalling	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	836	CASP3
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	23220	DTX4
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	2876	GPX1
R-HSA-3065679	SUMO is proteolytically processed	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	6612	SUMO3
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	3032	HADHB
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	2876	GPX1
R-HSA-3000484	Scavenging by Class F Receptors	0.22201518459868	-1.50500950035582	6	1	0.00297619047619048	336	8202	10808	HSPH1
R-HSA-5654738	Signaling by FGFR2	0.224059661607638	-1.49584291612835	316	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-180336	SHC1 events in EGFR signaling	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-5673001	RAF/MAP kinase cascade	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2254,2261,817,2335,6464,2263,2905,5721,5720,7414,1956	IRS1,FGF9,FGFR3,CAMK2D,FN1,SHC1,FGFR2,GRIN2C,PSME2,PSME1,VCL,EGFR
R-HSA-179812	GRB2 events in EGFR signaling	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-112412	SOS-mediated signalling	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.224995662931977	-1.49167415282138	228	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.227079170491361	-1.48245655362198	22	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.227079170491361	-1.48245655362198	22	2	0.00595238095238095	336	8202	5627,2149	PROS1,F2R
R-HSA-190236	Signaling by FGFR	0.227750767976394	-1.47950337083285	317	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-5683057	MAPK family signaling cascades	0.229245272004389	-1.47296279181226	273	14	0.0416666666666667	336	8202	3725,3667,2261,2254,817,6464,2335,2905,2263,5721,5720,3337,7414,1956	JUN,IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,DNAJB1,VCL,EGFR
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.22935901222991	-1.47246676405254	229	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.22935901222991	-1.47246676405254	229	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.22935901222991	-1.47246676405254	229	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.22935901222991	-1.47246676405254	229	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-2172127	DAP12 interactions	0.230238340084255	-1.46864024537109	340	17	0.0505952380952381	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2905,2263,5290,3107,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,GRIN2C,FGFR2,PIK3CA,HLA-C,VCL
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.230545855446875	-1.46730549729918	60	4	0.0119047619047619	336	8202	51434,5720,11065,5721	ANAPC7,PSME1,UBE2C,PSME2
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.232832746469821	-1.45743490948688	101	6	0.0178571428571429	336	8202	30061,64924,27173,204962,6513,9123	SLC40A1,SLC30A5,SLC39A1,SLC44A5,SLC2A1,SLC16A3
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.237401214256132	-1.43800368200865	81	5	0.0148809523809524	336	8202	8737,10010,9636,3659,1660	RIPK1,TANK,ISG15,IRF1,DHX9
R-HSA-1227986	Signaling by ERBB2	0.238978970169986	-1.43137972184262	320	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,PIK3CA,VCL
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.239448759256634	-1.42941583384556	61	4	0.0119047619047619	336	8202	56603,1591,66002,2232	CYP26B1,CYP24A1,CYP4F12,FDXR
R-HSA-70895	Branched-chain amino acid catabolism	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	1738,223	DLD,ALDH9A1
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	51434,11065	ANAPC7,UBE2C
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	2254,6464	FGF9,SHC1
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	134353,6628	LSM11,SNRPB
R-HSA-201451	Signaling by BMP	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	650,9765	BMP2,ZFYVE16
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.242435555974076	-1.41701935248252	23	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-170984	ARMS-mediated activation	0.242649567507548	-1.41613698550403	232	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-187706	Signalling to p38 via RIT and RIN	0.242649567507548	-1.41613698550403	232	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-1266738	Developmental Biology	0.245078370998414	-1.40617723796245	710	33	0.0982142857142857	336	8202	1948,2335,375790,5721,5087,5720,1947,2261,85441,6464,2905,1291,6386,7414,7074,6774,9475,9353,2254,1292,5468,5588,214,51129,1956,3667,817,2263,160,3912,3685,7026,10371	EFNB2,FN1,AGRN,PSME2,PBX1,PSME1,EFNB1,FGFR3,HELZ2,SHC1,GRIN2C,COL6A1,SDCBP,VCL,TIAM1,STAT3,ROCK2,SLIT2,FGF9,COL6A2,PPARG,PRKCQ,ALCAM,ANGPTL4,EGFR,IRS1,CAMK2D,FGFR2,AP2A1,LAMB1,ITGAV,NR2F2,SEMA3A
R-HSA-15869	Metabolism of nucleotides	0.245088755146457	-1.40613486813595	82	5	0.0148809523809524	336	8202	847,1890,50484,2876,4907	CAT,TYMP,RRM2B,GPX1,NT5E
R-HSA-170968	Frs2-mediated activation	0.247144109481106	-1.39778367329387	233	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-5684996	MAPK1/MAPK3 signaling	0.251669562383058	-1.37963831230957	234	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-71291	Metabolism of amino acids and derivatives	0.252104926802371	-1.37790990193135	212	11	0.0327380952380952	336	8202	53905,1728,6821,5721,548596,6303,51582,5720,1738,223,7263	DUOX1,NQO1,SUOX,PSME2,CKMT1A,SAT1,AZIN1,PSME1,DLD,ALDH9A1,TST
R-HSA-453276	Regulation of mitotic cell cycle	0.252841087135158	-1.3749941016912	83	5	0.0148809523809524	336	8202	51434,5720,891,11065,5721	ANAPC7,PSME1,CCNB1,UBE2C,PSME2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.252841087135158	-1.3749941016912	83	5	0.0148809523809524	336	8202	51434,5720,891,11065,5721	ANAPC7,PSME1,CCNB1,UBE2C,PSME2
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.252841087135158	-1.3749941016912	83	5	0.0148809523809524	336	8202	3978,6118,6612,1643,7508	LIG1,RPA2,SUMO3,DDB2,XPC
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	160	AP2A1
R-HSA-447043	Neurofascin interactions	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	6386	SDCBP
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	64924	SLC30A5
R-HSA-196791	Vitamin D (calciferol) metabolism	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	1591	CYP24A1
R-HSA-3595177	Defective CHSY1 causes TPBS	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	1462	VCAN
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	3978	LIG1
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	182	JAG1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	1462	VCAN
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	9249	DHRS3
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	1462	VCAN
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	182	JAG1
R-HSA-427601	Multifunctional anion exchangers	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	65010	SLC26A6
R-HSA-2214320	Anchoring fibril formation	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	3909	LAMA3
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.253909144820578	-1.37077877350941	7	1	0.00297619047619048	336	8202	8313	AXIN2
R-HSA-169893	Prolonged ERK activation events	0.256225149930584	-1.36169872911263	235	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-400253	Circadian Clock	0.257483593740657	-1.35679927453666	63	4	0.0119047619047619	336	8202	1408,85441,8204,3091	CRY2,HELZ2,NRIP1,HIF1A
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.257834356745693	-1.3554379283663	24	2	0.00595238095238095	336	8202	4193,1026	MDM2,CDKN1A
R-HSA-1614635	Sulfur amino acid metabolism	0.257834356745693	-1.3554379283663	24	2	0.00595238095238095	336	8202	6821,7263	SUOX,TST
R-HSA-70268	Pyruvate metabolism	0.257834356745693	-1.3554379283663	24	2	0.00595238095238095	336	8202	1738,9123	DLD,SLC16A3
R-HSA-73848	Pyrimidine metabolism	0.257834356745693	-1.3554379283663	24	2	0.00595238095238095	336	8202	1890,4907	TYMP,NT5E
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.257834356745693	-1.3554379283663	24	2	0.00595238095238095	336	8202	10846,5139	PDE10A,PDE3A
R-HSA-2424491	DAP12 signaling	0.258182836149879	-1.35408727779899	325	16	0.0476190476190476	336	8202	2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2905,2263,5290,7414	FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,GRIN2C,FGFR2,PIK3CA,VCL
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.266601785013417	-1.32199917578576	64	4	0.0119047619047619	336	8202	51434,5720,11065,5721	ANAPC7,PSME1,UBE2C,PSME2
R-HSA-382556	ABC-family proteins mediated transport	0.268707494996144	-1.31413187020247	44	3	0.00892857142857143	336	8202	8714,5825,5243	ABCC3,ABCD3,ABCB1
R-HSA-913531	Interferon Signaling	0.272450717946917	-1.3002975328054	194	10	0.0297619047619048	336	8202	817,10410,11274,6772,4940,3107,960,9636,6773,3659	CAMK2D,IFITM3,USP18,STAT1,OAS3,HLA-C,CD44,ISG15,STAT2,IRF1
R-HSA-1538133	G0 and Early G1	0.27324642007152	-1.29738125330493	25	2	0.00595238095238095	336	8202	7153,9134	TOP2A,CCNE2
R-HSA-210991	Basigin interactions	0.27324642007152	-1.29738125330493	25	2	0.00595238095238095	336	8202	3675,9123	ITGA3,SLC16A3
R-HSA-2262749	Cellular response to hypoxia	0.27324642007152	-1.29738125330493	25	2	0.00595238095238095	336	8202	112399,3091	EGLN3,HIF1A
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.27324642007152	-1.29738125330493	25	2	0.00595238095238095	336	8202	112399,3091	EGLN3,HIF1A
R-HSA-167044	Signalling to RAS	0.274732986927127	-1.29195560962793	239	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-69202	Cyclin E associated events during G1/S transition	0.275778129283979	-1.28815861595517	65	4	0.0119047619047619	336	8202	9134,5720,1026,5721	CCNE2,PSME1,CDKN1A,PSME2
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.275778129283979	-1.28815861595517	65	4	0.0119047619047619	336	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-397014	Muscle contraction	0.275778129283979	-1.28815861595517	65	4	0.0119047619047619	336	8202	59,7431,7414,301	ACTA2,VIM,VCL,ANXA1
R-HSA-1474290	Collagen formation	0.276443662065216	-1.28574823261323	86	5	0.0148809523809524	336	8202	1308,1292,3909,3691,1291	COL17A1,COL6A2,LAMA3,ITGB4,COL6A1
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.279958523069265	-1.27311381868098	45	3	0.00892857142857143	336	8202	3725,5986,6400	JUN,RFNG,SEL1L
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.279958523069265	-1.27311381868098	45	3	0.00892857142857143	336	8202	1738,6389,9123	DLD,SDHA,SLC16A3
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.284146854050475	-1.25826408273976	241	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.284412062128265	-1.2573311694058	87	5	0.0148809523809524	336	8202	677,5720,5721,3303,3304	ZFP36L1,PSME1,PSME2,HSPA1A,HSPA1B
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	301	ANXA1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	54894	RNF43
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	6513	SLC2A1
R-HSA-428643	Organic anion transporters	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	26503	SLC17A5
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	5627	PROS1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	5331	PLCB3
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	5331	PLCB3
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	1384	CRAT
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	2053	EPHX2
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	87	ACTN1
R-HSA-1483148	Synthesis of PG	0.28449932509373	-1.25702439767259	8	1	0.00297619047619048	336	8202	8760	CDS2
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.285005967185765	-1.25524516143876	66	4	0.0119047619047619	336	8202	9134,5720,1026,5721	CCNE2,PSME1,CDKN1A,PSME2
R-HSA-69206	G1/S Transition	0.288524054423536	-1.24297681895845	109	6	0.0178571428571429	336	8202	9134,6118,5720,1026,891,5721	CCNE2,RPA2,PSME1,CDKN1A,CCNB1,PSME2
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	3656,1660	IRAK2,DHX9
R-HSA-3781865	Diseases of glycosylation	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-264876	Insulin processing	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	64924,1363	SLC30A5,CPE
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-2029485	Role of phospholipids in phagocytosis	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	5295,5290	PIK3R1,PIK3CA
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	51384,79971	WNT16,WLS
R-HSA-77387	Insulin receptor recycling	0.288644897080284	-1.24255807620314	26	2	0.00595238095238095	336	8202	10312,523	TCIRG1,ATP6V1A
R-HSA-73893	DNA Damage Bypass	0.291252181429397	-1.23356578424393	46	3	0.00892857142857143	336	8202	6118,5429,9636	RPA2,POLH,ISG15
R-HSA-211945	Phase 1 - Functionalization of compounds	0.300474652483179	-1.20239187970214	89	5	0.0148809523809524	336	8202	56603,1591,8824,66002,2232	CYP26B1,CYP24A1,CES2,CYP4F12,FDXR
R-HSA-75109	Triglyceride Biosynthesis	0.303590002853687	-1.19207716267974	68	4	0.0119047619047619	336	8202	51495,8694,84803,6576	HACD3,DGAT1,GPAT3,SLC25A1
R-HSA-182971	EGFR downregulation	0.304005103899047	-1.19071078857525	27	2	0.00595238095238095	336	8202	160,1956	AP2A1,EGFR
R-HSA-114508	Effects of PIP2 hydrolysis	0.304005103899047	-1.19071078857525	27	2	0.00595238095238095	336	8202	5588,1609	PRKCQ,DGKQ
R-HSA-1368082	RORA activates gene expression	0.304005103899047	-1.19071078857525	27	2	0.00595238095238095	336	8202	85441,8204	HELZ2,NRIP1
R-HSA-187687	Signalling to ERKs	0.308094637109903	-1.17734827986044	246	12	0.0357142857142857	336	8202	3667,2261,2254,817,6464,2335,2905,2263,5721,5720,7414,1956	IRS1,FGFR3,FGF9,CAMK2D,SHC1,FN1,GRIN2C,FGFR2,PSME2,PSME1,VCL,EGFR
R-HSA-166520	Signalling by NGF	0.309399253305362	-1.17312275420949	430	20	0.0595238095238095	336	8202	836,2254,2335,5721,5295,5720,1026,1956,3667,817,2261,4193,6464,2263,2905,160,5290,6774,7074,7414	CASP3,FGF9,FN1,PSME2,PIK3R1,PSME1,CDKN1A,EGFR,IRS1,CAMK2D,FGFR3,MDM2,SHC1,FGFR2,GRIN2C,AP2A1,PIK3CA,STAT3,TIAM1,VCL
R-HSA-166054	Activated TLR4 signalling	0.310118633942715	-1.17080036457235	112	6	0.0178571428571429	336	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.312933422959593	-1.16176481726654	69	4	0.0119047619047619	336	8202	51434,5720,11065,5721	ANAPC7,PSME1,UBE2C,PSME2
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.312933422959593	-1.16176481726654	69	4	0.0119047619047619	336	8202	51434,5720,11065,5721	ANAPC7,PSME1,UBE2C,PSME2
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-391908	Prostanoid ligand receptors	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	5734	PTGER4
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	4595	MUTYH
R-HSA-196108	Pregnenolone biosynthesis	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	1738	DLD
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	160	AP2A1
R-HSA-425986	Sodium/Proton exchangers	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	10479	SLC9A6
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	9353	SLIT2
R-HSA-428543	Inactivation of Cdc42 and Rac	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	9353	SLIT2
R-HSA-73614	Pyrimidine salvage reactions	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	1890	TYMP
R-HSA-2179392	EGFR Transactivation by Gastrin	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	1956	EGFR
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	3091	HIF1A
R-HSA-2428933	SHC-related events triggered by IGF1R	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	6464	SHC1
R-HSA-159740	Gamma-carboxylation of protein precursors	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	5627	PROS1
R-HSA-3215018	Processing and activation of SUMO	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	6612	SUMO3
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.31383886948797	-1.15887557927962	9	1	0.00297619047619048	336	8202	5627	PROS1
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.319304390216184	-1.14161042985331	28	2	0.00595238095238095	336	8202	1174,160	AP1S1,AP2A1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.32230279614218	-1.13226381460986	70	4	0.0119047619047619	336	8202	51434,5720,11065,5721	ANAPC7,PSME1,UBE2C,PSME2
R-HSA-597592	Post-translational protein modification	0.325168427105085	-1.12341199364453	411	19	0.056547619047619	336	8202	10484,10678,7508,7039,6612,26503,672,79642,10610,8869,29926,4121,2517,1912,4905,5238,6400,5627,85365	SEC23A,B3GNT2,XPC,TGFA,SUMO3,SLC17A5,BRCA1,ARSJ,ST6GALNAC2,ST3GAL5,GMPPA,MAN1A1,FUCA1,PHC2,NSF,PGM3,SEL1L,PROS1,ALG2
R-HSA-202403	TCR signaling	0.331975718297027	-1.10269345039989	115	6	0.0178571428571429	336	8202	5588,5720,5721,3635,5295,5290	PRKCQ,PSME1,PSME2,INPP5D,PIK3R1,PIK3CA
R-HSA-1500620	Meiosis	0.331975718297027	-1.10269345039989	115	6	0.0178571428571429	336	8202	6118,653604,672,3306,23224,4000	RPA2,HIST2H3D,BRCA1,HSPA2,SYNE2,LMNA
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.33452201489855	-1.09505258723408	29	2	0.00595238095238095	336	8202	85441,860	HELZ2,RUNX2
R-HSA-445355	Smooth Muscle Contraction	0.33452201489855	-1.09505258723408	29	2	0.00595238095238095	336	8202	59,7414	ACTA2,VCL
R-HSA-917977	Transferrin endocytosis and recycling	0.33452201489855	-1.09505258723408	29	2	0.00595238095238095	336	8202	10312,523	TCIRG1,ATP6V1A
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.33452201489855	-1.09505258723408	29	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-180786	Extension of Telomeres	0.33452201489855	-1.09505258723408	29	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.33452201489855	-1.09505258723408	29	2	0.00595238095238095	336	8202	817,2905	CAMK2D,GRIN2C
R-HSA-112310	Neurotransmitter Release Cycle	0.336632226893488	-1.08876425940355	50	3	0.00892857142857143	336	8202	8541,10550,6505	PPFIA3,ARL6IP5,SLC1A1
R-HSA-209968	Thyroxine biosynthesis	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	53905	DUOX1
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	4595	MUTYH
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	6400	SEL1L
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	27173	SLC39A1
R-HSA-430116	GP1b-IX-V activation signalling	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	5295	PIK3R1
R-HSA-399997	Acetylcholine regulates insulin secretion	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	5331	PLCB3
R-HSA-419812	Calcitonin-like ligand receptors	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	133	ADM
R-HSA-2562578	TRIF-mediated programmed cell death	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	3725	JUN
R-HSA-190377	FGFR2b ligand binding and activation	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	2263	FGFR2
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	3656	IRAK2
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-2161522	Abacavir transport and metabolism	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	5243	ABCB1
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	1174	AP1S1
R-HSA-418889	Ligand-independent caspase activation via DCC	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	836	CASP3
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.341978762058697	-1.07300664309135	10	1	0.00297619047619048	336	8202	3656	IRAK2
R-HSA-383280	Nuclear Receptor transcription pathway	0.347976937734423	-1.05561907228177	51	3	0.00892857142857143	336	8202	5468,29959,7025	PPARG,NRBP1,NR2F1
R-HSA-948021	Transport to the Golgi and subsequent modification	0.349370590461153	-1.05162205637273	95	5	0.0148809523809524	336	8202	2517,10484,4905,7039,4121	FUCA1,SEC23A,NSF,TGFA,MAN1A1
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.349639028390118	-1.05085400416023	30	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.349639028390118	-1.05085400416023	30	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.350506583183378	-1.04837579042032	73	4	0.0119047619047619	336	8202	143686,27244,50484,2810	SESN3,SESN1,RRM2B,SFN
R-HSA-3700989	Transcriptional Regulation by TP53	0.350506583183378	-1.04837579042032	73	4	0.0119047619047619	336	8202	143686,27244,50484,2810	SESN3,SESN1,RRM2B,SFN
R-HSA-112315	Transmission across Chemical Synapses	0.358527047909107	-1.02575117434327	210	10	0.0297619047619048	336	8202	54331,817,4193,4905,2905,10550,160,8541,6505,5331	GNG2,CAMK2D,MDM2,NSF,GRIN2C,ARL6IP5,AP2A1,PPFIA3,SLC1A1,PLCB3
R-HSA-168256	Immune System	0.358655371135349	-1.02539332054149	1371	59	0.175595238095238	336	8202	3636,2335,523,9903,5721,3635,1326,6890,79654,1660,65264,8737,9666,5720,1026,3725,6494,2261,4193,6464,2905,10010,5290,51434,64219,5627,3107,79659,4940,960,6774,7414,64167,10484,2254,10952,10410,11274,5295,5588,26999,837,9636,1956,6773,3667,6892,817,1535,10312,2263,160,3656,6772,23220,1174,3685,11065,3659	INPPL1,FN1,ATP6V1A,KLHL21,PSME2,INPP5D,MAP3K8,TAP1,HECTD3,DHX9,UBE2Z,RIPK1,DZIP3,PSME1,CDKN1A,JUN,SIPA1,FGFR3,MDM2,SHC1,GRIN2C,TANK,PIK3CA,ANAPC7,PJA1,PROS1,HLA-C,DYNC2H1,OAS3,CD44,STAT3,VCL,ERAP2,SEC23A,FGF9,SEC61B,IFITM3,USP18,PIK3R1,PRKCQ,CYFIP2,CASP4,ISG15,EGFR,STAT2,IRS1,TAPBP,CAMK2D,CYBA,TCIRG1,FGFR2,AP2A1,IRAK2,STAT1,DTX4,AP1S1,ITGAV,UBE2C,IRF1
R-HSA-69541	Stabilization of p53	0.359302305141447	-1.02359116923769	52	3	0.00892857142857143	336	8202	5720,4193,5721	PSME1,MDM2,PSME2
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.359920421265389	-1.02187232400817	74	4	0.0119047619047619	336	8202	1912,6612,672,7508	PHC2,SUMO3,BRCA1,XPC
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.359920421265389	-1.02187232400817	74	4	0.0119047619047619	336	8202	1912,6612,672,7508	PHC2,SUMO3,BRCA1,XPC
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.363381844479853	-1.01230108442262	142	7	0.0208333333333333	336	8202	54331,817,4193,4905,2905,160,5331	GNG2,CAMK2D,MDM2,NSF,GRIN2C,AP2A1,PLCB3
R-HSA-167287	HIV elongation arrest and recovery	0.364638161473226	-1.00884975553009	31	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-2129379	Molecules associated with elastic fibres	0.364638161473226	-1.00884975553009	31	2	0.00595238095238095	336	8202	650,3685	BMP2,ITGAV
R-HSA-167290	Pausing and recovery of HIV elongation	0.364638161473226	-1.00884975553009	31	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-70263	Gluconeogenesis	0.364638161473226	-1.00884975553009	31	2	0.00595238095238095	336	8202	4190,6576	MDH1,SLC25A1
R-HSA-168638	NOD1/2 Signaling Pathway	0.364638161473226	-1.00884975553009	31	2	0.00595238095238095	336	8202	837,3656	CASP4,IRAK2
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.364638161473226	-1.00884975553009	31	2	0.00595238095238095	336	8202	3303,3304	HSPA1A,HSPA1B
R-HSA-879518	Transport of organic anions	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	28232	SLCO3A1
R-HSA-2022923	Dermatan sulfate biosynthesis	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	1462	VCAN
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-71288	Creatine metabolism	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	548596	CKMT1A
R-HSA-199983	Golgi to ER Retrograde Transport	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	1314	COPA
R-HSA-199997	COPI Mediated Transport	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	1314	COPA
R-HSA-1980148	Signaling by NOTCH3	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	182	JAG1
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	836	CASP3
R-HSA-71064	Lysine catabolism	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	1738	DLD
R-HSA-1266695	Interleukin-7 signaling	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	5295	PIK3R1
R-HSA-1236977	Endosomal/Vacuolar pathway	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	3107	HLA-C
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-196807	Nicotinate metabolism	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	93100	NAPRT
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	1535	CYBA
R-HSA-1980150	Signaling by NOTCH4	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	182	JAG1
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.368967914397479	-0.99704559157459	11	1	0.00297619047619048	336	8202	5627	PROS1
R-HSA-1221632	Meiotic synapsis	0.36933125782382	-0.996061319969403	75	4	0.0119047619047619	336	8202	672,3306,23224,4000	BRCA1,HSPA2,SYNE2,LMNA
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.370599435568021	-0.992633488154107	53	3	0.00892857142857143	336	8202	5720,5721,60489	PSME1,PSME2,APOBEC3G
R-HSA-2187338	Visual phototransduction	0.374019530010537	-0.983447263651473	98	5	0.0148809523809524	336	8202	26020,5588,375790,9249,157506	LRP10,PRKCQ,AGRN,DHRS3,RDH10
R-HSA-69239	Synthesis of DNA	0.374019530010537	-0.983447263651473	98	5	0.0148809523809524	336	8202	3978,6118,5720,1026,5721	LIG1,RPA2,PSME1,CDKN1A,PSME2
R-HSA-416476	G alpha (q) signalling events	0.37616260730251	-0.977733762848731	190	9	0.0267857142857143	336	8202	54331,1609,5295,5290,5588,5997,2149,301,5331	GNG2,DGKQ,PIK3R1,PIK3CA,PRKCQ,RGS2,F2R,ANXA1,PLCB3
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.376165340656455	-0.977726496459245	121	6	0.0178571428571429	336	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-428157	Sphingolipid metabolism	0.378733747334684	-0.970921834406841	76	4	0.0119047619047619	336	8202	79642,9517,3074,8612	ARSJ,SPTLC2,HEXB,PLPP2
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.379503720102871	-0.968890879551886	32	2	0.00595238095238095	336	8202	54331,5331	GNG2,PLCB3
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.379503720102871	-0.968890879551886	32	2	0.00595238095238095	336	8202	54331,2149	GNG2,F2R
R-HSA-114604	GPVI-mediated activation cascade	0.381859842069653	-0.962701643278705	54	3	0.00892857142857143	336	8202	6464,5295,5290	SHC1,PIK3R1,PIK3CA
R-HSA-4641257	Degradation of AXIN	0.381859842069653	-0.962701643278705	54	3	0.00892857142857143	336	8202	5720,5721,8313	PSME1,PSME2,AXIN2
R-HSA-70326	Glucose metabolism	0.388122700505597	-0.946433750935206	77	4	0.0119047619047619	336	8202	5836,4190,5236,6576	PYGL,MDH1,PGM1,SLC25A1
R-HSA-2142753	Arachidonic acid metabolism	0.393075440397972	-0.933753725234714	55	3	0.00892857142857143	336	8202	2053,4048,2876	EPHX2,LTA4H,GPX1
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.393075440397972	-0.933753725234714	55	3	0.00892857142857143	336	8202	5720,5721,6400	PSME1,PSME2,SEL1L
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.393075440397972	-0.933753725234714	55	3	0.00892857142857143	336	8202	5720,5721,6400	PSME1,PSME2,SEL1L
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.394221485955305	-0.930842380535008	33	2	0.00595238095238095	336	8202	5087,6774	PBX1,STAT3
R-HSA-69190	DNA strand elongation	0.394221485955305	-0.930842380535008	33	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-933541	TRAF6 mediated IRF7 activation	0.394221485955305	-0.930842380535008	33	2	0.00595238095238095	336	8202	10010,3659	TANK,IRF1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.394221485955305	-0.930842380535008	33	2	0.00595238095238095	336	8202	672,197342	BRCA1,EME2
R-HSA-5694530	Cargo concentration in the ER	0.394221485955305	-0.930842380535008	33	2	0.00595238095238095	336	8202	10484,7039	SEC23A,TGFA
R-HSA-3371511	HSF1 activation	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-190373	FGFR1c ligand binding and activation	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	375790	AGRN
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	375790	AGRN
R-HSA-211979	Eicosanoids	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	66002	CYP4F12
R-HSA-432047	Passive transport by Aquaporins	0.394853249621862	-0.929241103056301	12	1	0.00297619047619048	336	8202	360	AQP3
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.397493086585803	-0.92257773727597	78	4	0.0119047619047619	336	8202	85441,7026,5468,51129	HELZ2,NR2F2,PPARG,ANGPTL4
R-HSA-69242	S Phase	0.405737338579615	-0.902049278053707	125	6	0.0178571428571429	336	8202	3978,9134,6118,5720,1026,5721	LIG1,CCNE2,RPA2,PSME1,CDKN1A,PSME2
R-HSA-2990846	SUMOylation	0.406840035170533	-0.899335204776675	79	4	0.0119047619047619	336	8202	1912,6612,672,7508	PHC2,SUMO3,BRCA1,XPC
R-HSA-113418	Formation of the Early Elongation Complex	0.408778622504559	-0.894581534746288	34	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.408778622504559	-0.894581534746288	34	2	0.00595238095238095	336	8202	2254,2263	FGF9,FGFR2
R-HSA-5693537	Resolution of D-Loop Structures	0.408778622504559	-0.894581534746288	34	2	0.00595238095238095	336	8202	672,197342	BRCA1,EME2
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.408778622504559	-0.894581534746288	34	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.41534185860734	-0.878653342171601	57	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.41534185860734	-0.878653342171601	57	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.41534185860734	-0.878653342171601	57	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.41534185860734	-0.878653342171601	57	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.41534185860734	-0.878653342171601	57	3	0.00892857142857143	336	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	51	ACOX1
R-HSA-211227	Activation of DNA fragmentation factor	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	836	CASP3
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	51	ACOX1
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	6513	SLC2A1
R-HSA-75205	Dissolution of Fibrin Clot	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	6281	S100A10
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	23220	DTX4
R-HSA-174403	Glutathione synthesis and recycling	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	2937	GSS
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	1660	DHX9
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	4000	LMNA
R-HSA-140342	Apoptosis induced DNA fragmentation	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	836	CASP3
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	160	AP2A1
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	8821	INPP4B
R-HSA-2995410	Nuclear Envelope Reassembly	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	4000	LMNA
R-HSA-5626467	RHO GTPases activate IQGAPs	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	10788	IQGAP2
R-HSA-4641265	Repression of WNT target genes	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	7088	TLE1
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	64428	NARFL
R-HSA-1483213	Synthesis of PE	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	1119	CHKA
R-HSA-177504	Retrograde neurotrophin signalling	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	160	AP2A1
R-HSA-1663150	The activation of arylsulfatases	0.419679782968135	-0.868263280000253	13	1	0.00297619047619048	336	8202	79642	ARSJ
R-HSA-432720	Lysosome Vesicle Biogenesis	0.423163586226437	-0.859996446028416	35	2	0.00595238095238095	336	8202	2799,1174	GNS,AP1S1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.434693983416067	-0.833112981855968	82	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.434693983416067	-0.833112981855968	82	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.434693983416067	-0.833112981855968	82	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.437366042763489	-0.826984808038744	36	2	0.00595238095238095	336	8202	5627,79642	PROS1,ARSJ
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.437366042763489	-0.826984808038744	36	2	0.00595238095238095	336	8202	1591,2232	CYP24A1,FDXR
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.437366042763489	-0.826984808038744	36	2	0.00595238095238095	336	8202	9517,8612	SPTLC2,PLPP2
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.437366042763489	-0.826984808038744	36	2	0.00595238095238095	336	8202	6464,5295	SHC1,PIK3R1
R-HSA-69306	DNA Replication	0.439488352415857	-0.822144064106023	106	5	0.0148809523809524	336	8202	3978,6118,5720,1026,5721	LIG1,RPA2,PSME1,CDKN1A,PSME2
R-HSA-162594	Early Phase of HIV Life Cycle	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	3978	LIG1
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-428540	Activation of Rac	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	9353	SLIT2
R-HSA-69166	Removal of the Flap Intermediate	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-190322	FGFR4 ligand binding and activation	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	10371	SEMA3A
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	1738	DLD
R-HSA-877312	Regulation of IFNG signaling	0.443490699185735	-0.81307844884872	14	1	0.00297619047619048	336	8202	6772	STAT1
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.443901724996795	-0.812152081146555	83	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-73857	RNA Polymerase II Transcription	0.447585183283033	-0.803888405677093	107	5	0.0148809523809524	336	8202	6827,6829,134353,6628,51616	SUPT4H1,SUPT5H,LSM11,SNRPB,TAF9B
R-HSA-450294	MAP kinase activation in TLR cascade	0.448225863894388	-0.802458013134801	60	3	0.00892857142857143	336	8202	3725,1326,3656	JUN,MAP3K8,IRAK2
R-HSA-438064	Post NMDA receptor activation events	0.451376787774908	-0.795452838661463	37	2	0.00595238095238095	336	8202	817,2905	CAMK2D,GRIN2C
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.451376787774908	-0.795452838661463	37	2	0.00595238095238095	336	8202	6118,672	RPA2,BRCA1
R-HSA-421270	Cell-cell junction organization	0.459024679651232	-0.778651302063719	61	3	0.00892857142857143	336	8202	81607,25945,5818	PVRL4,PVRL3,PVRL1
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.462177266029509	-0.771806768787055	85	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.462177266029509	-0.771806768787055	85	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-5696398	Nucleotide Excision Repair	0.463687544519399	-0.768544349020754	109	5	0.0148809523809524	336	8202	3978,6118,6612,1643,7508	LIG1,RPA2,SUMO3,DDB2,XPC
R-HSA-5674135	MAP2K and MAPK activation	0.465187672078749	-0.765314358949409	38	2	0.00595238095238095	336	8202	2335,7414	FN1,VCL
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.465187672078749	-0.765314358949409	38	2	0.00595238095238095	336	8202	1643,7508	DDB2,XPC
R-HSA-69236	G1 Phase	0.465187672078749	-0.765314358949409	38	2	0.00595238095238095	336	8202	1031,1026	CDKN2C,CDKN1A
R-HSA-69231	Cyclin D associated events in G1	0.465187672078749	-0.765314358949409	38	2	0.00595238095238095	336	8202	1031,1026	CDKN2C,CDKN1A
R-HSA-3322077	Glycogen synthesis	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	5236	PGM1
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	196513	DCP1B
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	2335	FN1
R-HSA-211935	Fatty acids	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	66002	CYP4F12
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	23220	DTX4
R-HSA-391903	Eicosanoid ligand-binding receptors	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	5734	PTGER4
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	2810	SFN
R-HSA-159418	Recycling of bile acids and salts	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	8714	ABCC3
R-HSA-901042	Calnexin/calreticulin cycle	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	6400	SEL1L
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.466327426721992	-0.762867259136478	15	1	0.00297619047619048	336	8202	160	AP2A1
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.478791531193644	-0.736489993020234	39	2	0.00595238095238095	336	8202	6118,672	RPA2,BRCA1
R-HSA-110312	Translesion synthesis by REV1	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	1326	MAP3K8
R-HSA-399956	CRMPs in Sema3A signaling	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	10371	SEMA3A
R-HSA-156711	Polo-like kinase mediated events	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	3656	IRAK2
R-HSA-392517	Rap1 signalling	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	6494	SIPA1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	136	ADORA2B
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	516	ATP5G1
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	10371	SEMA3A
R-HSA-1834941	STING mediated induction of host immune responses	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	23220	DTX4
R-HSA-190242	FGFR1 ligand binding and activation	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-1369062	ABC transporters in lipid homeostasis	0.488229708943857	-0.716969268831678	16	1	0.00297619047619048	336	8202	5825	ABCD3
R-HSA-5687128	MAPK6/MAPK4 signaling	0.489184754459196	-0.715015039883687	88	4	0.0119047619047619	336	8202	3725,5720,3337,5721	JUN,PSME1,DNAJB1,PSME2
R-HSA-5358346	Hedgehog ligand biogenesis	0.490857309505526	-0.711601805428507	64	3	0.00892857142857143	336	8202	5720,5721,6400	PSME1,PSME2,SEL1L
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.490857309505526	-0.711601805428507	64	3	0.00892857142857143	336	8202	1308,1292,1291	COL17A1,COL6A2,COL6A1
R-HSA-1660662	Glycosphingolipid metabolism	0.492182118717993	-0.708906470986217	40	2	0.00595238095238095	336	8202	79642,3074	ARSJ,HEXB
R-HSA-5696400	Dual Incision in GG-NER	0.492182118717993	-0.708906470986217	40	2	0.00595238095238095	336	8202	6118,1643	RPA2,DDB2
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.492182118717993	-0.708906470986217	40	2	0.00595238095238095	336	8202	2495,10808	FTH1,HSPH1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.498065229851253	-0.697024226898038	89	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.50126436661321	-0.690621639199603	65	3	0.00892857142857143	336	8202	6827,6829,51616	SUPT4H1,SUPT5H,TAF9B
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.505354043534386	-0.682496019040255	41	2	0.00595238095238095	336	8202	817,2905	CAMK2D,GRIN2C
R-HSA-5620924	Intraflagellar transport	0.505354043534386	-0.682496019040255	41	2	0.00595238095238095	336	8202	79659,56912	DYNC2H1,IFT46
R-HSA-5656121	Translesion synthesis by POLI	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-5655862	Translesion synthesis by POLK	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	6400	SEL1L
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	3656	IRAK2
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	677	ZFP36L1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	9475	ROCK2
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	7941	PLA2G7
R-HSA-1482801	Acyl chain remodelling of PS	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	10162	LPCAT3
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.509235672526614	-0.674844358730278	17	1	0.00297619047619048	336	8202	8541	PPFIA3
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.511562385630685	-0.670285734985314	66	3	0.00892857142857143	336	8202	10484,4905,7039	SEC23A,NSF,TGFA
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.511562385630685	-0.670285734985314	66	3	0.00892857142857143	336	8202	8737,23220,1660	RIPK1,DTX4,DHX9
R-HSA-168898	Toll-Like Receptors Cascades	0.514496216322995	-0.664567077820604	140	6	0.0178571428571429	336	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-373752	Netrin-1 signaling	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	5588,9353	PRKCQ,SLIT2
R-HSA-73856	RNA Polymerase II Transcription Termination	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	134353,6628	LSM11,SNRPB
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	7088,6662	TLE1,SOX9
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	6118,672	RPA2,BRCA1
R-HSA-975634	Retinoid metabolism and transport	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	26020,375790	LRP10,AGRN
R-HSA-1566948	Elastic fibre formation	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	650,3685	BMP2,ITGAV
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.51830271061221	-0.657195823986896	42	2	0.00595238095238095	336	8202	134353,6628	LSM11,SNRPB
R-HSA-425407	SLC-mediated transmembrane transport	0.521480756593824	-0.651082905329856	264	11	0.0327380952380952	336	8202	30061,64924,10479,6513,65010,9123,26503,28232,6505,27173,204962	SLC40A1,SLC30A5,SLC9A6,SLC2A1,SLC26A6,SLC16A3,SLC17A5,SLCO3A1,SLC1A1,SLC39A1,SLC44A5
R-HSA-167172	Transcription of the HIV genome	0.521747556483249	-0.650571416345331	67	3	0.00892857142857143	336	8202	6827,6829,51616	SUPT4H1,SUPT5H,TAF9B
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.524297248841976	-0.645696486714811	92	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.524297248841976	-0.645696486714811	92	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.524297248841976	-0.645696486714811	92	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.524297248841976	-0.645696486714811	92	4	0.0119047619047619	336	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.529381892925306	-0.63604519278634	18	1	0.00297619047619048	336	8202	10010	TANK
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.529381892925306	-0.63604519278634	18	1	0.00297619047619048	336	8202	8541	PPFIA3
R-HSA-209776	Amine-derived hormones	0.529381892925306	-0.63604519278634	18	1	0.00297619047619048	336	8202	53905	DUOX1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.529381892925306	-0.63604519278634	18	1	0.00297619047619048	336	8202	8541	PPFIA3
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.531024265131083	-0.632947561738922	43	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.531024265131083	-0.632947561738922	43	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-167169	HIV Transcription Elongation	0.531024265131083	-0.632947561738922	43	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.531024265131083	-0.632947561738922	43	2	0.00595238095238095	336	8202	54331,360	GNG2,AQP3
R-HSA-388841	Costimulation by the CD28 family	0.531816366645718	-0.631457024705234	68	3	0.00892857142857143	336	8202	1326,5295,5290	MAP3K8,PIK3R1,PIK3CA
R-HSA-199977	ER to Golgi Anterograde Transport	0.531816366645718	-0.631457024705234	68	3	0.00892857142857143	336	8202	10484,4905,7039	SEC23A,NSF,TGFA
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.535423654946948	-0.624696967050902	143	6	0.0178571428571429	336	8202	516,4719,1738,6389,9123,7385	ATP5G1,NDUFS1,DLD,SDHA,SLC16A3,UQCRC2
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.543515539895182	-0.60969698056618	44	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.543515539895182	-0.60969698056618	44	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-112382	Formation of RNA Pol II elongation complex	0.543515539895182	-0.60969698056618	44	2	0.00595238095238095	336	8202	6827,6829	SUPT4H1,SUPT5H
R-HSA-446652	Interleukin-1 signaling	0.543515539895182	-0.60969698056618	44	2	0.00595238095238095	336	8202	1326,3656	MAP3K8,IRAK2
R-HSA-3000480	Scavenging by Class A Receptors	0.548703457429702	-0.60019713380766	19	1	0.00297619047619048	336	8202	2495	FTH1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.548703457429702	-0.60019713380766	19	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.548703457429702	-0.60019713380766	19	1	0.00297619047619048	336	8202	84617	TUBB6
R-HSA-68949	Orc1 removal from chromatin	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	5720,1026,5721	PSME1,CDKN1A,PSME2
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	11274,9636,6772	USP18,ISG15,STAT1
R-HSA-69052	Switching of origins to a post-replicative state	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	5720,1026,5721	PSME1,CDKN1A,PSME2
R-HSA-1169408	ISG15 antiviral mechanism	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	11274,9636,6772	USP18,ISG15,STAT1
R-HSA-421837	Clathrin derived vesicle budding	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	2799,1174,2495	GNS,AP1S1,FTH1
R-HSA-69473	G2/M DNA damage checkpoint	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	672,891,2810	BRCA1,CCNB1,SFN
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.551592283685816	-0.594946122127813	70	3	0.00892857142857143	336	8202	2799,1174,2495	GNS,AP1S1,FTH1
R-HSA-162906	HIV Infection	0.556108552883892	-0.586791764788401	221	9	0.0267857142857143	336	8202	6827,5721,160,3978,1174,5720,6829,60489,51616	SUPT4H1,PSME2,AP2A1,LIG1,AP1S1,PSME1,SUPT5H,APOBEC3G,TAF9B
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.558218031666086	-0.583005655166101	96	4	0.0119047619047619	336	8202	26503,6505,10479,65010	SLC17A5,SLC1A1,SLC9A6,SLC26A6
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.567129548771327	-0.567167520274033	223	9	0.0267857142857143	336	8202	9903,5721,79654,9666,65264,5720,51434,64219,11065	KLHL21,PSME2,HECTD3,DZIP3,UBE2Z,PSME1,ANAPC7,PJA1,UBE2C
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.567797725089482	-0.565990041486195	46	2	0.00595238095238095	336	8202	51495,6576	HACD3,SLC25A1
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.567797725089482	-0.565990041486195	46	2	0.00595238095238095	336	8202	2261,2254	FGFR3,FGF9
R-HSA-418597	G alpha (z) signalling events	0.567797725089482	-0.565990041486195	46	2	0.00595238095238095	336	8202	54331,5588	GNG2,PRKCQ
R-HSA-69300	Removal of licensing factors from origins	0.570867613429952	-0.560597946592955	72	3	0.00892857142857143	336	8202	5720,1026,5721	PSME1,CDKN1A,PSME2
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.579585307470358	-0.545442418286937	47	2	0.00595238095238095	336	8202	837,3656	CASP4,IRAK2
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.579585307470358	-0.545442418286937	47	2	0.00595238095238095	336	8202	7088,3091	TLE1,HIF1A
R-HSA-2024096	HS-GAG degradation	0.585005886586353	-0.536133369260133	21	1	0.00297619047619048	336	8202	375790	AGRN
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.585005886586353	-0.536133369260133	21	1	0.00297619047619048	336	8202	55157	DARS2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.585005886586353	-0.536133369260133	21	1	0.00297619047619048	336	8202	54894	RNF43
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.585005886586353	-0.536133369260133	21	1	0.00297619047619048	336	8202	3489	IGFBP6
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.585005886586353	-0.536133369260133	21	1	0.00297619047619048	336	8202	84617	TUBB6
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.585005886586353	-0.536133369260133	21	1	0.00297619047619048	336	8202	50484	RRM2B
R-HSA-168249	Innate Immune System	0.590659087216226	-0.526516268594257	752	30	0.0892857142857143	336	8202	2254,2335,5721,1326,5295,1660,8737,5588,5720,1026,26999,837,1956,9636,3725,3667,817,2261,4193,6464,2905,2263,10010,3656,5290,23220,3107,5627,7414,3659	FGF9,FN1,PSME2,MAP3K8,PIK3R1,DHX9,RIPK1,PRKCQ,PSME1,CDKN1A,CYFIP2,CASP4,EGFR,ISG15,JUN,IRS1,CAMK2D,FGFR3,MDM2,SHC1,GRIN2C,FGFR2,TANK,IRAK2,PIK3CA,DTX4,HLA-C,PROS1,VCL,IRF1
R-HSA-73887	Death Receptor Signalling	0.591135868722493	-0.525709391682592	48	2	0.00595238095238095	336	8202	8737,355	RIPK1,FAS
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.591135868722493	-0.525709391682592	48	2	0.00595238095238095	336	8202	54700,9219	RRN3,MTA2
R-HSA-3214842	HDMs demethylate histones	0.591135868722493	-0.525709391682592	48	2	0.00595238095238095	336	8202	653604,10765	HIST2H3D,KDM5B
R-HSA-69304	Regulation of DNA replication	0.598802826083384	-0.512822906869671	75	3	0.00892857142857143	336	8202	5720,1026,5721	PSME1,CDKN1A,PSME2
R-HSA-162909	Host Interactions of HIV factors	0.600103208956672	-0.510653623631075	127	5	0.0148809523809524	336	8202	1174,5720,5721,160,60489	AP1S1,PSME1,PSME2,AP2A1,APOBEC3G
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.602050015914911	-0.507414754209376	22	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.602050015914911	-0.507414754209376	22	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.602050015914911	-0.507414754209376	22	1	0.00297619047619048	336	8202	157506	RDH10
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.602050015914911	-0.507414754209376	22	1	0.00297619047619048	336	8202	6774	STAT3
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.602050015914911	-0.507414754209376	22	1	0.00297619047619048	336	8202	2517	FUCA1
R-HSA-390466	Chaperonin-mediated protein folding	0.602448991828166	-0.506752278067374	49	2	0.00595238095238095	336	8202	84617,8237	TUBB6,USP11
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.602448991828166	-0.506752278067374	49	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.602448991828166	-0.506752278067374	49	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.606555260863369	-0.499959440382051	102	4	0.0119047619047619	336	8202	516,4719,6389,7385	ATP5G1,NDUFS1,SDHA,UQCRC2
R-HSA-2132295	MHC class II antigen presentation	0.606555260863369	-0.499959440382051	102	4	0.0119047619047619	336	8202	1174,10484,79659,160	AP1S1,SEC23A,DYNC2H1,AP2A1
R-HSA-74160	Gene Expression	0.612369534133238	-0.490419364748903	1330	53	0.157738095238095	336	8202	6209,57343,860,5721,134353,196513,6235,8270,1660,7576,677,5720,85456,3303,79042,23521,6164,85441,54700,143686,6134,6170,94039,653604,6207,171392,7050,6159,10952,6133,5468,6628,6160,9219,79862,6142,6829,27244,4781,7025,3304,6189,51616,10940,6827,10520,6158,6210,50484,55157,80818,29959,2810	RPS15,ZNF304,RUNX2,PSME2,LSM11,DCP1B,RPS29,LAGE3,DHX9,ZNF28,ZFP36L1,PSME1,TNKS1BP1,HSPA1A,TSEN34,RPL13A,RPL34,HELZ2,RRN3,SESN3,RPL10,RPL39,ZNF101,HIST2H3D,RPS13,ZNF675,TGIF1,RPL29,SEC61B,RPL9,PPARG,SNRPB,RPL31,MTA2,ZNF669,RPL18A,SUPT5H,SESN1,NFIB,NR2F1,HSPA1B,RPS3A,TAF9B,POP1,SUPT4H1,ZNF211,RPL28,RPS15A,RRM2B,DARS2,ZNF436,NRBP1,SFN
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.613524690380735	-0.488534770521612	50	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.613524690380735	-0.488534770521612	50	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-169911	Regulation of Apoptosis	0.613524690380735	-0.488534770521612	50	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-2980766	Nuclear Envelope Breakdown	0.613524690380735	-0.488534770521612	50	2	0.00595238095238095	336	8202	891,4000	CCNB1,LMNA
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.613524690380735	-0.488534770521612	50	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-429914	Deadenylation-dependent mRNA decay	0.613524690380735	-0.488534770521612	50	2	0.00595238095238095	336	8202	85456,196513	TNKS1BP1,DCP1B
R-HSA-2871837	FCERI mediated NF-kB activation	0.616754492997201	-0.483284238642253	77	3	0.00892857142857143	336	8202	5588,5720,5721	PRKCQ,PSME1,PSME2
R-HSA-73980	RNA Polymerase III Transcription Termination	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	4781	NFIB
R-HSA-429947	Deadenylation of mRNA	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	85456	TNKS1BP1
R-HSA-1482839	Acyl chain remodelling of PE	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	10162	LPCAT3
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	7050	TGIF1
R-HSA-428930	Thromboxane signalling through TP receptor	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	8541	PPFIA3
R-HSA-211976	Endogenous sterols	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	4048	LTA4H
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.618396127732058	-0.480626043481347	23	1	0.00297619047619048	336	8202	123016	TTC8
R-HSA-180534	Vpu mediated degradation of CD4	0.624363374150929	-0.471022749731165	51	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-445717	Aquaporin-mediated transport	0.624363374150929	-0.471022749731165	51	2	0.00595238095238095	336	8202	54331,360	GNG2,AQP3
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.624363374150929	-0.471022749731165	51	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.624363374150929	-0.471022749731165	51	2	0.00595238095238095	336	8202	2254,2263	FGF9,FGFR2
R-HSA-418346	Platelet homeostasis	0.625524949261695	-0.469164062961448	78	3	0.00892857142857143	336	8202	54331,10846,5139	GNG2,PDE10A,PDE3A
R-HSA-69481	G2/M Checkpoints	0.629483185141925	-0.462856137304969	105	4	0.0119047619047619	336	8202	6118,672,891,2810	RPA2,BRCA1,CCNB1,SFN
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.634072726459451	-0.455591620619792	24	1	0.00297619047619048	336	8202	9475	ROCK2
R-HSA-977606	Regulation of Complement cascade	0.634072726459451	-0.455591620619792	24	1	0.00297619047619048	336	8202	5627	PROS1
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.634072726459451	-0.455591620619792	24	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-933542	TRAF6 mediated NF-kB activation	0.634072726459451	-0.455591620619792	24	1	0.00297619047619048	336	8202	1660	DHX9
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.634965816907269	-0.454184113180516	52	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.634965816907269	-0.454184113180516	52	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-69610	p53-Independent DNA Damage Response	0.634965816907269	-0.454184113180516	52	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-422356	Regulation of insulin secretion	0.642650693075443	-0.442153947961717	80	3	0.00892857142857143	336	8202	54331,6513,5331	GNG2,SLC2A1,PLCB3
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-977068	Termination of O-glycan biosynthesis	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	10610	ST6GALNAC2
R-HSA-1296059	G protein gated Potassium channels	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-114452	Activation of BH3-only proteins	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	2810	SFN
R-HSA-1482788	Acyl chain remodelling of PC	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	10162	LPCAT3
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	51495	HACD3
R-HSA-1296041	Activation of G protein gated Potassium channels	0.64910715590395	-0.432157466656001	25	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-611105	Respiratory electron transport	0.65100476020474	-0.429238324657843	81	3	0.00892857142857143	336	8202	4719,6389,7385	NDUFS1,SDHA,UQCRC2
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.65100476020474	-0.429238324657843	81	3	0.00892857142857143	336	8202	7088,5720,5721	TLE1,PSME1,PSME2
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.655466713828347	-0.422407756887176	54	2	0.00595238095238095	336	8202	375790,1462	AGRN,VCAN
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.655466713828347	-0.422407756887176	54	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.655466713828347	-0.422407756887176	54	2	0.00595238095238095	336	8202	1174,2495	AP1S1,FTH1
R-HSA-68874	M/G1 Transition	0.659219093507108	-0.416699336141434	82	3	0.00892857142857143	336	8202	6118,5720,5721	RPA2,PSME1,PSME2
R-HSA-69002	DNA Replication Pre-Initiation	0.659219093507108	-0.416699336141434	82	3	0.00892857142857143	336	8202	6118,5720,5721	RPA2,PSME1,PSME2
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.663525646254386	-0.410187772973633	26	1	0.00297619047619048	336	8202	672	BRCA1
R-HSA-983189	Kinesins	0.663525646254386	-0.410187772973633	26	1	0.00297619047619048	336	8202	3833	KIFC1
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.663525646254386	-0.410187772973633	26	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-391251	Protein folding	0.665368271313874	-0.407414600162743	55	2	0.00595238095238095	336	8202	84617,8237	TUBB6,USP11
R-HSA-6784531	tRNA processing in the nucleus	0.665368271313874	-0.407414600162743	55	2	0.00595238095238095	336	8202	10940,79042	POP1,TSEN34
R-HSA-4641258	Degradation of DVL	0.675039742698501	-0.392983711771	56	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-912446	Meiotic recombination	0.675227916223203	-0.392704991437772	84	3	0.00892857142857143	336	8202	6118,653604,672	RPA2,HIST2H3D,BRCA1
R-HSA-111885	Opioid Signalling	0.675227916223203	-0.392704991437772	84	3	0.00892857142857143	336	8202	54331,5142,5331	GNG2,PDE4B,PLCB3
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.677353359418881	-0.389562193317759	27	1	0.00297619047619048	336	8202	84617	TUBB6
R-HSA-180024	DARPP-32 events	0.677353359418881	-0.389562193317759	27	1	0.00297619047619048	336	8202	5142	PDE4B
R-HSA-400685	Sema4D in semaphorin signaling	0.677353359418881	-0.389562193317759	27	1	0.00297619047619048	336	8202	9475	ROCK2
R-HSA-437239	Recycling pathway of L1	0.677353359418881	-0.389562193317759	27	1	0.00297619047619048	336	8202	160	AP2A1
R-HSA-2022854	Keratan sulfate biosynthesis	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	10678	B3GNT2
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	6829	SUPT5H
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	84617	TUBB6
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	51719	CAB39
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	6829	SUPT5H
R-HSA-202040	G-protein activation	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-1483166	Synthesis of PA	0.690614432363645	-0.370173595947993	28	1	0.00297619047619048	336	8202	84803	GPAT3
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.690677332095676	-0.370082522166634	86	3	0.00892857142857143	336	8202	26999,5295,5290	CYFIP2,PIK3R1,PIK3CA
R-HSA-2980736	Peptide hormone metabolism	0.690677332095676	-0.370082522166634	86	3	0.00892857142857143	336	8202	7941,64924,1363	PLA2G7,SLC30A5,CPE
R-HSA-195721	Signaling by Wnt	0.691132813107227	-0.369423269476055	326	12	0.0357142857142857	336	8202	54331,5721,79971,160,6662,8313,7088,653604,5720,54894,51384,5331	GNG2,PSME2,WLS,AP2A1,SOX9,AXIN2,TLE1,HIST2H3D,PSME1,RNF43,WNT16,PLCB3
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.69370133165706	-0.365713768948699	58	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.69370133165706	-0.365713768948699	58	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.698192912725424	-0.359259835142692	87	3	0.00892857142857143	336	8202	653604,7088,8313	HIST2H3D,TLE1,AXIN2
R-HSA-373080	Class B/2 (Secretin family receptors)	0.698192912725424	-0.359259835142692	87	3	0.00892857142857143	336	8202	54331,51384,133	GNG2,WNT16,ADM
R-HSA-382551	Transmembrane transport of small molecules	0.698994064432968	-0.358113028296586	586	22	0.0654761904761905	336	8202	30061,64924,523,6513,65010,9123,6262,2495,360,26503,28232,6505,27173,54331,6337,10312,5825,10479,5243,6446,8714,204962	SLC40A1,SLC30A5,ATP6V1A,SLC2A1,SLC26A6,SLC16A3,RYR2,FTH1,AQP3,SLC17A5,SLCO3A1,SLC1A1,SLC39A1,GNG2,SCNN1A,TCIRG1,ABCD3,SLC9A6,ABCB1,SGK1,ABCC3,SLC44A5
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.702696400702925	-0.35283034289341	59	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.702696400702925	-0.35283034289341	59	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.702696400702925	-0.35283034289341	59	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.702696400702925	-0.35283034289341	59	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.703332018710185	-0.35192621031432	29	1	0.00297619047619048	336	8202	8237	USP11
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.703332018710185	-0.35192621031432	29	1	0.00297619047619048	336	8202	3725	JUN
R-HSA-977225	Amyloid formation	0.705569671252193	-0.348749758132576	88	3	0.00892857142857143	336	8202	653604,2934,1471	HIST2H3D,GSN,CST3
R-HSA-3858494	Beta-catenin independent WNT signaling	0.70901199073567	-0.343882840412948	144	5	0.0148809523809524	336	8202	54331,5720,5721,160,5331	GNG2,PSME1,PSME2,AP2A1,PLCB3
R-HSA-68882	Mitotic Anaphase	0.713254346335993	-0.33791719520083	172	6	0.0178571428571429	336	8202	51434,5720,11065,5721,4000,55143	ANAPC7,PSME1,UBE2C,PSME2,LMNA,CDCA8
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.7155283287084	-0.334734087885552	30	1	0.00297619047619048	336	8202	3725	JUN
R-HSA-420092	Glucagon-type ligand receptors	0.7155283287084	-0.334734087885552	30	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.7155283287084	-0.334734087885552	30	1	0.00297619047619048	336	8202	6464	SHC1
R-HSA-68962	Activation of the pre-replicative complex	0.7155283287084	-0.334734087885552	30	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-72086	mRNA Capping	0.7155283287084	-0.334734087885552	30	1	0.00297619047619048	336	8202	6829	SUPT5H
R-HSA-5683826	Surfactant metabolism	0.7155283287084	-0.334734087885552	30	1	0.00297619047619048	336	8202	136	ADORA2B
R-HSA-73894	DNA Repair	0.715930650809073	-0.334171973124286	306	11	0.0327380952380952	336	8202	6118,1643,7508,197342,3978,6612,672,2189,5429,4595,9636	RPA2,DDB2,XPC,EME2,LIG1,SUMO3,BRCA1,FANCG,POLH,MUTYH,ISG15
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.718465592947014	-0.330637461948574	173	6	0.0178571428571429	336	8202	51434,5720,11065,5721,4000,55143	ANAPC7,PSME1,UBE2C,PSME2,LMNA,CDCA8
R-HSA-196854	Metabolism of vitamins and cofactors	0.719909191117823	-0.328630198373735	90	3	0.00892857142857143	336	8202	93100,113278,6513	NAPRT,SLC52A3,SLC2A1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.719909191117823	-0.328630198373735	90	3	0.00892857142857143	336	8202	93100,113278,6513	NAPRT,SLC52A3,SLC2A1
R-HSA-4086398	Ca2+ pathway	0.720028757556961	-0.328464126718324	61	2	0.00595238095238095	336	8202	54331,5331	GNG2,PLCB3
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.720028757556961	-0.328464126718324	61	2	0.00595238095238095	336	8202	836,7074	CASP3,TIAM1
R-HSA-4086400	PCP/CE pathway	0.726873447366246	-0.319002891751048	91	3	0.00892857142857143	336	8202	5720,5721,160	PSME1,PSME2,AP2A1
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-1296065	Inwardly rectifying K+ channels	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-73772	RNA Polymerase I Promoter Escape	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	54700	RRN3
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	7050	TGIF1
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	4325	MMP16
R-HSA-5357905	Regulation of TNFR1 signaling	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-2022928	HS-GAG biosynthesis	0.7272246676099	-0.318519815338436	31	1	0.00297619047619048	336	8202	375790	AGRN
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.736503974263252	-0.305840646945672	63	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-4608870	Asymmetric localization of PCP proteins	0.736503974263252	-0.305840646945672	63	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-392518	Signal amplification	0.73844147237162	-0.303213432187032	32	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.73844147237162	-0.303213432187032	32	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-376176	Signaling by Robo receptor	0.73844147237162	-0.303213432187032	32	1	0.00297619047619048	336	8202	9353	SLIT2
R-HSA-913709	O-linked glycosylation of mucins	0.744428060225227	-0.295139059834173	64	2	0.00595238095238095	336	8202	10678,10610	B3GNT2,ST6GALNAC2
R-HSA-72306	tRNA processing	0.746955145828814	-0.291750141396697	94	3	0.00892857142857143	336	8202	10940,79042,8270	POP1,TSEN34,LAGE3
R-HSA-113510	E2F mediated regulation of DNA replication	0.749198346946339	-0.288751514839706	33	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.749198346946339	-0.288751514839706	33	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.749198346946339	-0.288751514839706	33	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-112316	Neuronal System	0.753279897909427	-0.283318409878344	289	10	0.0297619047619048	336	8202	54331,817,4193,4905,2905,10550,160,8541,6505,5331	GNG2,CAMK2D,MDM2,NSF,GRIN2C,ARL6IP5,AP2A1,PPFIA3,SLC1A1,PLCB3
R-HSA-194840	Rho GTPase cycle	0.754023086981351	-0.282332292104282	124	4	0.0119047619047619	336	8202	58480,54509,7074,23526	RHOU,RHOF,TIAM1,HMHA1
R-HSA-390522	Striated Muscle Contraction	0.759514096178174	-0.275076397305277	34	1	0.00297619047619048	336	8202	7431	VIM
R-HSA-4791275	Signaling by WNT in cancer	0.759514096178174	-0.275076397305277	34	1	0.00297619047619048	336	8202	54894	RNF43
R-HSA-3928663	EPHA-mediated growth cone collapse	0.759514096178174	-0.275076397305277	34	1	0.00297619047619048	336	8202	9475	ROCK2
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.759514096178174	-0.275076397305277	34	1	0.00297619047619048	336	8202	5588	PRKCQ
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.759514096178174	-0.275076397305277	34	1	0.00297619047619048	336	8202	9636	ISG15
R-HSA-1169091	Activation of NF-kappaB in B cells	0.759665828713431	-0.274876641459014	66	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-373755	Semaphorin interactions	0.766986390948756	-0.265286220994254	67	2	0.00595238095238095	336	8202	10371,9475	SEMA3A,ROCK2
R-HSA-5658442	Regulation of RAS by GAPs	0.766986390948756	-0.265286220994254	67	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-68867	Assembly of the pre-replicative complex	0.766986390948756	-0.265286220994254	67	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-2514856	The phototransduction cascade	0.769406758235178	-0.262135504929219	35	1	0.00297619047619048	336	8202	5588	PRKCQ
R-HSA-194068	Bile acid and bile salt metabolism	0.769406758235178	-0.262135504929219	35	1	0.00297619047619048	336	8202	8714	ABCC3
R-HSA-2672351	Stimuli-sensing channels	0.777789007122083	-0.251299990656737	99	3	0.00892857142857143	336	8202	6262,6446,6337	RYR2,SGK1,SCNN1A
R-HSA-5610787	Hedgehog 'off' state	0.777789007122083	-0.251299990656737	99	3	0.00892857142857143	336	8202	5720,79659,5721	PSME1,DYNC2H1,PSME2
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.778893635807647	-0.249880781833425	36	1	0.00297619047619048	336	8202	26999	CYFIP2
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.778893635807647	-0.249880781833425	36	1	0.00297619047619048	336	8202	1956	EGFR
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.780845735662195	-0.247377670211693	129	4	0.0119047619047619	336	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.787991326047302	-0.238268196739027	37	1	0.00297619047619048	336	8202	1956	EGFR
R-HSA-176187	Activation of ATR in response to replication stress	0.787991326047302	-0.238268196739027	37	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-2299718	Condensation of Prophase Chromosomes	0.794362520620034	-0.230215346845488	71	2	0.00595238095238095	336	8202	653604,891	HIST2H3D,CCNB1
R-HSA-2467813	Separation of Sister Chromatids	0.795381947629513	-0.228932842431011	161	5	0.0148809523809524	336	8202	51434,5720,11065,5721,55143	ANAPC7,PSME1,UBE2C,PSME2,CDCA8
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.796715749128433	-0.227257314837852	38	1	0.00297619047619048	336	8202	28232	SLCO3A1
R-HSA-1442490	Collagen degradation	0.796715749128433	-0.227257314837852	38	1	0.00297619047619048	336	8202	1308	COL17A1
R-HSA-166658	Complement cascade	0.796715749128433	-0.227257314837852	38	1	0.00297619047619048	336	8202	5627	PROS1
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.796715749128433	-0.227257314837852	38	1	0.00297619047619048	336	8202	9636	ISG15
R-HSA-977444	GABA B receptor activation	0.805082175923452	-0.216810924881088	39	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.805082175923452	-0.216810924881088	39	1	0.00297619047619048	336	8202	1738	DLD
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.805082175923452	-0.216810924881088	39	1	0.00297619047619048	336	8202	8270	LAGE3
R-HSA-991365	Activation of GABAB receptors	0.805082175923452	-0.216810924881088	39	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-165159	mTOR signalling	0.805082175923452	-0.216810924881088	39	1	0.00297619047619048	336	8202	51719	CAB39
R-HSA-5693538	Homology Directed Repair	0.80992172997621	-0.210817665643599	135	4	0.0119047619047619	336	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-5358351	Signaling by Hedgehog	0.80992172997621	-0.210817665643599	135	4	0.0119047619047619	336	8202	5720,79659,5721,6400	PSME1,DYNC2H1,PSME2,SEL1L
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.81310525429798	-0.206894713732921	40	1	0.00297619047619048	336	8202	4781	NFIB
R-HSA-168253	Host Interactions with Influenza Factors	0.81310525429798	-0.206894713732921	40	1	0.00297619047619048	336	8202	9636	ISG15
R-HSA-74158	RNA Polymerase III Transcription	0.81310525429798	-0.206894713732921	40	1	0.00297619047619048	336	8202	4781	NFIB
R-HSA-109703	PKB-mediated events	0.81310525429798	-0.206894713732921	40	1	0.00297619047619048	336	8202	51719	CAB39
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.81888879229095	-0.199806989097186	137	4	0.0119047619047619	336	8202	3833,653604,50808,3659	KIFC1,HIST2H3D,AK3,IRF1
R-HSA-163685	Integration of energy metabolism	0.820655832524546	-0.197651462628393	107	3	0.00892857142857143	336	8202	54331,6513,5331	GNG2,SLC2A1,PLCB3
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.820655832524546	-0.197651462628393	107	3	0.00892857142857143	336	8202	653604,54700,9219	HIST2H3D,RRN3,MTA2
R-HSA-75893	TNF signaling	0.820799034557987	-0.1974769807871	41	1	0.00297619047619048	336	8202	8737	RIPK1
R-HSA-70153	Glucose transport	0.820799034557987	-0.1974769807871	41	1	0.00297619047619048	336	8202	6513	SLC2A1
R-HSA-379724	tRNA Aminoacylation	0.828176993685022	-0.188528386951238	42	1	0.00297619047619048	336	8202	55157	DARS2
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.828176993685022	-0.188528386951238	42	1	0.00297619047619048	336	8202	85441	HELZ2
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.828176993685022	-0.188528386951238	42	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.830107657923647	-0.18619987826115	77	2	0.00595238095238095	336	8202	9134,1026	CCNE2,CDKN1A
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.830107657923647	-0.18619987826115	77	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-73864	RNA Polymerase I Transcription	0.830208078830075	-0.186078912225199	109	3	0.00892857142857143	336	8202	653604,54700,9219	HIST2H3D,RRN3,MTA2
R-HSA-199991	Membrane Trafficking	0.830328302984629	-0.185934110634484	256	8	0.0238095238095238	336	8202	2799,10484,1314,4905,7039,1174,2495,2810	GNS,SEC23A,COPA,NSF,TGFA,AP1S1,FTH1,SFN
R-HSA-162587	HIV Life Cycle	0.831686076662369	-0.184300221064783	140	4	0.0119047619047619	336	8202	3978,6827,6829,51616	LIG1,SUPT4H1,SUPT5H,TAF9B
R-HSA-201681	TCF dependent signaling in response to WNT	0.835152260279804	-0.180141223114108	229	7	0.0208333333333333	336	8202	653604,7088,54894,5720,5721,6662,8313	HIST2H3D,TLE1,RNF43,PSME1,PSME2,SOX9,AXIN2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.835252058660627	-0.180021733024421	43	1	0.00297619047619048	336	8202	7050	TGIF1
R-HSA-157579	Telomere Maintenance	0.83549141342283	-0.179735208171456	78	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-5668914	Diseases of metabolism	0.848542597569934	-0.164234992185642	45	1	0.00297619047619048	336	8202	2232	FDXR
R-HSA-193648	NRAGE signals death through JNK	0.848542597569934	-0.164234992185642	45	1	0.00297619047619048	336	8202	7074	TIAM1
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.851341871430493	-0.160941502019769	145	4	0.0119047619047619	336	8202	653604,54700,4781,9219	HIST2H3D,RRN3,NFIB,MTA2
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	51616	TAF9B
R-HSA-73776	RNA Polymerase II Promoter Escape	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	51616	TAF9B
R-HSA-112043	PLC beta mediated events	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	5331	PLCB3
R-HSA-167161	HIV Transcription Initiation	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	51616	TAF9B
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	51616	TAF9B
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	51616	TAF9B
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.854781372516394	-0.156909547402576	46	1	0.00297619047619048	336	8202	51616	TAF9B
R-HSA-193704	p75 NTR receptor-mediated signalling	0.855518910003792	-0.156047081857017	82	2	0.00595238095238095	336	8202	836,7074	CASP3,TIAM1
R-HSA-5653656	Vesicle-mediated transport	0.857941361891568	-0.153219524613369	294	9	0.0267857142857143	336	8202	2799,10484,10808,1314,4905,7039,1174,2495,2810	GNS,SEC23A,HSPH1,COPA,NSF,TGFA,AP1S1,FTH1,SFN
R-HSA-112040	G-protein mediated events	0.860763895668627	-0.149935033218381	47	1	0.00297619047619048	336	8202	5331	PLCB3
R-HSA-189200	Hexose transport	0.860763895668627	-0.149935033218381	47	1	0.00297619047619048	336	8202	6513	SLC2A1
R-HSA-1640170	Cell Cycle	0.861108065645965	-0.149535270646419	572	19	0.056547619047619	336	8202	9134,5721,23224,55143,3978,5720,672,1026,891,4000,1031,6118,7153,4193,653604,51434,11065,3306,2810	CCNE2,PSME2,SYNE2,CDCA8,LIG1,PSME1,BRCA1,CDKN1A,CCNB1,LMNA,CDKN2C,RPA2,TOP2A,MDM2,HIST2H3D,ANAPC7,UBE2C,HSPA2,SFN
R-HSA-5632684	Hedgehog 'on' state	0.86467714708014	-0.145399082091561	84	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.866500662194942	-0.143292405608716	48	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.872001738661766	-0.136963861196973	49	1	0.00297619047619048	336	8202	2254	FGF9
R-HSA-191859	snRNP Assembly	0.877276780478724	-0.130932737223334	50	1	0.00297619047619048	336	8202	6628	SNRPB
R-HSA-194441	Metabolism of non-coding RNA	0.877276780478724	-0.130932737223334	50	1	0.00297619047619048	336	8202	6628	SNRPB
R-HSA-72165	mRNA Splicing - Minor Pathway	0.877276780478724	-0.130932737223334	50	1	0.00297619047619048	336	8202	6628	SNRPB
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.882335048591517	-0.12518342142256	51	1	0.00297619047619048	336	8202	123016	TTC8
R-HSA-1592230	Mitochondrial biogenesis	0.882335048591517	-0.12518342142256	51	1	0.00297619047619048	336	8202	85441	HELZ2
R-HSA-1268020	Mitochondrial protein import	0.887185425675599	-0.119701270407782	52	1	0.00297619047619048	336	8202	516	ATP5G1
R-HSA-5625740	RHO GTPases activate PKNs	0.889053043289827	-0.117598379005417	90	2	0.00595238095238095	336	8202	653604,2810	HIST2H3D,SFN
R-HSA-162599	Late Phase of HIV Life Cycle	0.898144768369132	-0.107424011680842	127	3	0.00892857142857143	336	8202	6827,6829,51616	SUPT4H1,SUPT5H,TAF9B
R-HSA-977443	GABA receptor activation	0.900572681259875	-0.104724405507821	55	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-3214815	HDACs deacetylate histones	0.902975296386974	-0.102060083207393	94	2	0.00595238095238095	336	8202	653604,9219	HIST2H3D,MTA2
R-HSA-5693532	DNA Double-Strand Break Repair	0.904250187639045	-0.100649200642022	162	4	0.0119047619047619	336	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.909309681790495	-0.0950695587863401	96	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-5693607	Processing of DNA double-strand break ends	0.912330027126075	-0.0917534825188653	97	2	0.00595238095238095	336	8202	6118,672	RPA2,BRCA1
R-HSA-983712	Ion channel transport	0.913784824194143	-0.090160157351186	198	5	0.0148809523809524	336	8202	6262,6446,6337,10312,523	RYR2,SGK1,SCNN1A,TCIRG1,ATP6V1A
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.918090444544279	-0.0854593697460517	99	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-212436	Generic Transcription Pathway	0.918972480841869	-0.0844991017517664	553	17	0.0505952380952381	336	8202	171392,7050,57343,860,5468,79862,7576,27244,7025,85441,143686,10520,50484,94039,80818,29959,2810	ZNF675,TGIF1,ZNF304,RUNX2,PPARG,ZNF669,ZNF28,SESN1,NR2F1,HELZ2,SESN3,ZNF211,RRM2B,ZNF101,ZNF436,NRBP1,SFN
R-HSA-73728	RNA Polymerase I Promoter Opening	0.919457075269418	-0.0839719187143071	60	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.920835716186003	-0.0824736341142803	100	2	0.00595238095238095	336	8202	891,55143	CCNB1,CDCA8
R-HSA-68875	Mitotic Prophase	0.921979484125369	-0.0812323071640347	136	3	0.00892857142857143	336	8202	653604,891,4000	HIST2H3D,CCNB1,LMNA
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.922780880559334	-0.0803634718402498	61	1	0.00297619047619048	336	8202	26999	CYFIP2
R-HSA-68886	M Phase	0.92398650400934	-0.0790578134976198	296	8	0.0238095238095238	336	8202	5721,55143,653604,5720,51434,891,11065,4000	PSME2,CDCA8,HIST2H3D,PSME1,ANAPC7,CCNB1,UBE2C,LMNA
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.925967912135488	-0.0769156970578599	62	1	0.00297619047619048	336	8202	2810	SFN
R-HSA-5334118	DNA methylation	0.925967912135488	-0.0769156970578599	62	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-5173105	O-linked glycosylation	0.928561802844727	-0.0741183383746677	103	2	0.00595238095238095	336	8202	10678,10610	B3GNT2,ST6GALNAC2
R-HSA-69278	Cell Cycle, Mitotic	0.930587688231256	-0.071938969584684	477	14	0.0416666666666667	336	8202	7153,9134,6118,1031,5721,55143,3978,653604,5720,51434,1026,891,11065,4000	TOP2A,CCNE2,RPA2,CDKN2C,PSME2,CDCA8,LIG1,HIST2H3D,PSME1,ANAPC7,CDKN1A,CCNB1,UBE2C,LMNA
R-HSA-6782135	Dual incision in TC-NER	0.93195387293294	-0.0704719580825667	64	1	0.00297619047619048	336	8202	6118	RPA2
R-HSA-3214841	PKMTs methylate histone lysines	0.93195387293294	-0.0704719580825667	64	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.93195387293294	-0.0704719580825667	64	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-73886	Chromosome Maintenance	0.933311660039285	-0.0690160931430519	105	2	0.00595238095238095	336	8202	3978,6118	LIG1,RPA2
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.934763346847656	-0.0674618867056896	65	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-68877	Mitotic Prometaphase	0.939880501455252	-0.0620025379107306	108	2	0.00595238095238095	336	8202	891,55143	CCNB1,CDCA8
R-HSA-1632852	Macroautophagy	0.940040045189355	-0.0618328033602246	67	1	0.00297619047619048	336	8202	55062	WIPI1
R-HSA-5617833	Assembly of the primary cilium	0.941470475301229	-0.0603122905893556	180	4	0.0119047619047619	336	8202	123016,79659,79867,56912	TTC8,DYNC2H1,TCTN2,IFT46
R-HSA-194315	Signaling by Rho GTPases	0.942027733207251	-0.059720564067116	399	11	0.0327380952380952	336	8202	58480,1535,23526,55143,653604,54509,26999,7074,9475,2810,10788	RHOU,CYBA,HMHA1,CDCA8,HIST2H3D,RHOF,CYFIP2,TIAM1,ROCK2,SFN,IQGAP2
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.942516571895482	-0.0592017769015703	68	1	0.00297619047619048	336	8202	672	BRCA1
R-HSA-212300	PRC2 methylates histones and DNA	0.947167825662404	-0.054278983268839	70	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-72163	mRNA Splicing - Major Pathway	0.949485760594576	-0.0518347455830849	113	2	0.00595238095238095	336	8202	6628,1660	SNRPB,DHX9
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.951443753919301	-0.0497747070574973	72	1	0.00297619047619048	336	8202	7050	TGIF1
R-HSA-195258	RHO GTPase Effectors	0.951521474782428	-0.0496930231023751	285	7	0.0208333333333333	336	8202	653604,26999,1535,9475,2810,10788,55143	HIST2H3D,CYFIP2,CYBA,ROCK2,SFN,IQGAP2,CDCA8
R-HSA-380287	Centrosome maturation	0.95345050653331	-0.0476677624380101	73	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.95345050653331	-0.0476677624380101	73	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.955374559896671	-0.0456518060794895	74	1	0.00297619047619048	336	8202	672	BRCA1
R-HSA-3214858	RMTs methylate histone arginines	0.957219312352567	-0.0437227472712075	75	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-5693606	DNA Double Strand Break Response	0.957219312352567	-0.0437227472712075	75	1	0.00297619047619048	336	8202	672	BRCA1
R-HSA-72172	mRNA Splicing	0.960508502053551	-0.0402924451171779	120	2	0.00595238095238095	336	8202	6628,1660	SNRPB,DHX9
R-HSA-5621481	C-type lectin receptors (CLRs)	0.964491894175472	-0.0361538508443255	123	2	0.00595238095238095	336	8202	5720,5721	PSME1,PSME2
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.966795966510305	-0.0337678021616103	81	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-162582	Signal Transduction	0.969607057453966	-0.0308643849663014	2357	82	0.244047619047619	336	8202	836,375790,523,5721,8737,54894,5720,1026,54509,92737,5139,5331,9765,4193,182,6464,2905,220,5290,7414,7074,2149,1738,1292,79971,23526,5734,5588,133,54331,58480,817,1535,10312,6772,6400,51719,7088,7433,2335,6662,1609,5142,55143,136,3337,5997,9249,57534,10788,3725,650,2261,10846,1291,8313,653604,51384,79659,6774,154796,9475,56603,2254,7050,157506,5295,54492,26999,9564,1956,301,355,3667,2263,5986,3091,160,23220,26020,3685,2810	CASP3,AGRN,ATP6V1A,PSME2,RIPK1,RNF43,PSME1,CDKN1A,RHOF,DNER,PDE3A,PLCB3,ZFYVE16,MDM2,JAG1,SHC1,GRIN2C,ALDH1A3,PIK3CA,VCL,TIAM1,F2R,DLD,COL6A2,WLS,HMHA1,PTGER4,PRKCQ,ADM,GNG2,RHOU,CAMK2D,CYBA,TCIRG1,STAT1,SEL1L,CAB39,TLE1,VIPR1,FN1,SOX9,DGKQ,PDE4B,CDCA8,ADORA2B,DNAJB1,RGS2,DHRS3,MIB1,IQGAP2,JUN,BMP2,FGFR3,PDE10A,COL6A1,AXIN2,HIST2H3D,WNT16,DYNC2H1,STAT3,AMOT,ROCK2,CYP26B1,FGF9,TGIF1,RDH10,PIK3R1,NEURL1B,CYFIP2,BCAR1,EGFR,ANXA1,FAS,IRS1,FGFR2,RFNG,HIF1A,AP2A1,DTX4,LRP10,ITGAV,SFN
R-HSA-5419276	Mitochondrial translation termination	0.970749638571527	-0.0296866826892277	84	1	0.00297619047619048	336	8202	55173	MRPS10
R-HSA-5389840	Mitochondrial translation elongation	0.970749638571527	-0.0296866826892277	84	1	0.00297619047619048	336	8202	55173	MRPS10
R-HSA-5368286	Mitochondrial translation initiation	0.970749638571527	-0.0296866826892277	84	1	0.00297619047619048	336	8202	55173	MRPS10
R-HSA-73777	RNA Polymerase I Chain Elongation	0.975300617739118	-0.0250095296206725	88	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.977303982894995	-0.0229575362389241	90	1	0.00297619047619048	336	8202	79867	TCTN2
R-HSA-5368287	Mitochondrial translation	0.977303982894995	-0.0229575362389241	90	1	0.00297619047619048	336	8202	55173	MRPS10
R-HSA-3214847	HATs acetylate histones	0.982716880752894	-0.0174342158301929	143	2	0.00595238095238095	336	8202	54556,653604	ING3,HIST2H3D
R-HSA-1296071	Potassium Channels	0.984493238774988	-0.0156282486004977	99	1	0.00297619047619048	336	8202	54331	GNG2
R-HSA-5578749	Transcriptional regulation by small RNAs	0.985752662469058	-0.0143498052703428	101	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-427413	NoRC negatively regulates rRNA expression	0.987453134694041	-0.0126262418707325	104	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.988019888578693	-0.0120524512965001	153	2	0.00595238095238095	336	8202	6628,1660	SNRPB,DHX9
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.988951180779757	-0.0111103107822712	107	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-5663220	RHO GTPases Activate Formins	0.991789126829264	-0.00824476805509113	114	1	0.00297619047619048	336	8202	55143	CDCA8
R-HSA-69275	G2/M Transition	0.992130231350351	-0.00790089871076285	115	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.992130231350351	-0.00790089871076285	115	1	0.00297619047619048	336	8202	3107	HLA-C
R-HSA-1852241	Organelle biogenesis and maintenance	0.992224324352477	-0.00780606384173665	321	6	0.0178571428571429	336	8202	55173,123016,85441,79659,79867,56912	MRPS10,TTC8,HELZ2,DYNC2H1,TCTN2,IFT46
R-HSA-453274	Mitotic G2-G2/M phases	0.992770633798835	-0.00725562470040982	117	1	0.00297619047619048	336	8202	891	CCNB1
R-HSA-212165	Epigenetic regulation of gene expression	0.99462954920448	-0.00538492350630452	124	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-4839726	Chromatin organization	0.995021474727761	-0.00499095941548058	261	4	0.0119047619047619	336	8202	54556,653604,10765,9219	ING3,HIST2H3D,KDM5B,MTA2
R-HSA-3247509	Chromatin modifying enzymes	0.995021474727761	-0.00499095941548058	261	4	0.0119047619047619	336	8202	54556,653604,10765,9219	ING3,HIST2H3D,KDM5B,MTA2
R-HSA-211000	Gene Silencing by RNA	0.995838291713929	-0.00417039229591858	130	1	0.00297619047619048	336	8202	653604	HIST2H3D
R-HSA-375276	Peptide ligand-binding receptors	0.99732787989508	-0.00267569659046739	193	2	0.00595238095238095	336	8202	2149,301	F2R,ANXA1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999261320711169	-0.000738952246803583	318	4	0.0119047619047619	336	8202	136,2149,5734,301	ADORA2B,F2R,PTGER4,ANXA1
R-HSA-500792	GPCR ligand binding	0.999401732951293	-0.000598446081847659	444	7	0.0208333333333333	336	8202	54331,51384,136,2149,133,5734,301	GNG2,WNT16,ADORA2B,F2R,ADM,PTGER4,ANXA1
R-HSA-372790	Signaling by GPCR	0.999485442787204	-0.000514689642788995	1230	31	0.0922619047619048	336	8202	7433,2254,2335,5721,1609,5295,5142,5734,5588,5720,136,5997,133,5139,1956,5331,301,54331,3667,2261,817,6464,2905,2263,10846,5290,51384,7414,7074,2149,9475	VIPR1,FGF9,FN1,PSME2,DGKQ,PIK3R1,PDE4B,PTGER4,PRKCQ,PSME1,ADORA2B,RGS2,ADM,PDE3A,EGFR,PLCB3,ANXA1,GNG2,IRS1,FGFR3,CAMK2D,SHC1,GRIN2C,FGFR2,PDE10A,PIK3CA,WNT16,VCL,TIAM1,F2R,ROCK2
R-HSA-418594	G alpha (i) signalling events	0.999492464858127	-0.000507663981428438	236	2	0.00595238095238095	336	8202	54331,301	GNG2,ANXA1
R-HSA-388396	GPCR downstream signaling	0.999905248651158	-9.47558380348771e-05	928	19	0.056547619047619	336	8202	7433,1609,5295,5142,5734,5588,136,5997,133,5139,5331,301,54331,6464,10846,5290,2149,7074,9475	VIPR1,DGKQ,PIK3R1,PDE4B,PTGER4,PRKCQ,ADORA2B,RGS2,ADM,PDE3A,PLCB3,ANXA1,GNG2,SHC1,PDE10A,PIK3CA,F2R,TIAM1,ROCK2
R-HSA-416700	Other semaphorin interactions	0.999999999975486	-2.45137758573343e-11	19	0	0	336	8202
R-HSA-190861	Gap junction assembly	0.999999999975486	-2.45137758573343e-11	19	0	0	336	8202
R-HSA-1181150	Signaling by NODAL	0.999999999975486	-2.45137758573343e-11	19	0	0	336	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999975486	-2.45137758573343e-11	19	0	0	336	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999975486	-2.45137758573343e-11	19	0	0	336	8202
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999975486	-2.45137758573343e-11	19	0	0	336	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999977384	-2.26163921304999e-11	18	0	0	336	8202
R-HSA-5635838	Activation of SMO	0.999999999977384	-2.26163921304999e-11	18	0	0	336	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999977384	-2.26163921304999e-11	18	0	0	336	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999977384	-2.26163921304999e-11	18	0	0	336	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999977384	-2.26163921304999e-11	18	0	0	336	8202
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.999999999977384	-2.26163921304999e-11	18	0	0	336	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-1170546	Prolactin receptor signaling	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-193639	p75NTR signals via NF-kB	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-1433559	Regulation of KIT signaling	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-163615	PKA activation	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-5625900	RHO GTPases activate CIT	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.99999999997961	-2.0390203822022e-11	16	0	0	336	8202
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.999999999980208	-1.97917533559571e-11	24	0	0	336	8202
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999980208	-1.97917533559571e-11	24	0	0	336	8202
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.999999999980208	-1.97917533559571e-11	24	0	0	336	8202
R-HSA-5260271	Diseases of Immune System	0.999999999980208	-1.97917533559571e-11	24	0	0	336	8202
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.999999999980208	-1.97917533559571e-11	24	0	0	336	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-68952	DNA replication initiation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-70921	Histidine catabolism	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-388479	Vasopressin-like receptors	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-500753	Pyrimidine biosynthesis	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-171052	LDL-mediated lipid transport	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-190370	FGFR1b ligand binding and activation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-1237112	Methionine salvage pathway	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-171319	Telomere Extension By Telomerase	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-77111	Synthesis of Ketone Bodies	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-111957	Cam-PDE 1 activation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-187015	Activation of TRKA receptors	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-73942	DNA Damage Reversal	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-428808	Na+-dependent glucose transporters	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-444257	RSK activation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-166662	Lectin pathway of complement activation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-189483	Heme degradation	0.99999999998118	-1.88203772433232e-11	6	0	0	336	8202
R-HSA-166663	Initial triggering of complement	0.99999999998314	-1.68602092833115e-11	20	0	0	336	8202
R-HSA-210745	Regulation of gene expression in beta cells	0.99999999998314	-1.68602092833115e-11	20	0	0	336	8202
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.99999999998314	-1.68602092833115e-11	20	0	0	336	8202
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.99999999998314	-1.68602092833115e-11	20	0	0	336	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-916853	Degradation of GABA	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-168268	Virus Assembly and Release	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-1483101	Synthesis of PS	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-192905	vRNP Assembly	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-844623	The IPAF inflammasome	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-380612	Metabolism of serotonin	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-156582	Acetylation	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-888568	GABA synthesis	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-165160	PDE3B signalling	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-198765	Signalling to ERK5	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-70688	Proline catabolism	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-187042	TRKA activation by NGF	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-75094	Formation of the Editosome	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-1483226	Synthesis of PI	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999983729	-1.62711703919488e-11	2	0	0	336	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-549132	Organic cation/anion/zwitterion transport	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-194223	HDL-mediated lipid transport	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-975577	N-Glycan antennae elongation	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.999999999984047	-1.59526949415955e-11	15	0	0	336	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-265473	Trafficking of dietary sterols	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-70350	Fructose catabolism	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1483152	Hydrolysis of LPE	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-77108	Utilization of Ketone Bodies	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-191650	Regulation of gap junction activity	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-163282	Mitochondrial transcription initiation	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-193681	Ceramide signalling	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-977347	Serine biosynthesis	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-844455	The NLRP1 inflammasome	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1296067	Potassium transport channels	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-977442	GABA A (rho) receptor activation	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-217271	FMO oxidises nucleophiles	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-844615	The AIM2 inflammasome	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.99999999998625	-1.37504890151052e-11	3	0	0	336	8202
R-HSA-168325	Viral Messenger RNA Synthesis	0.999999999986819	-1.31814506794748e-11	41	0	0	336	8202
R-HSA-167021	PLC-gamma1 signalling	0.999999999987033	-1.29674277289662e-11	36	0	0	336	8202
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999987033	-1.29674277289662e-11	36	0	0	336	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-389542	NADPH regeneration	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-3248023	Regulation by TREX1	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-169131	Inhibition of PKR	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1483076	Synthesis of CL	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-140180	COX reactions	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1300645	Acrosome Reaction	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5619084	ABC transporter disorders	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999987715	-1.22847981787189e-11	1	0	0	336	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-156587	Amino Acid conjugation	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-162592	Integration of provirus	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-425381	Bicarbonate transporters	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-70635	Urea cycle	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-390696	Adrenoceptors	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-193697	p75NTR regulates axonogenesis	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-447041	CHL1 interactions	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-1462054	Alpha-defensins	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999987812	-1.21878200184342e-11	9	0	0	336	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-168799	Neurotoxicity of clostridium toxins	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-381183	ATF6-alpha activates chaperone genes	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-419771	Opsins	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-418886	Netrin mediated repulsion signals	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-549127	Organic cation transport	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-5621480	Dectin-2 family	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-190873	Gap junction degradation	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999988525	-1.14752237503992e-11	10	0	0	336	8202
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-196780	Biotin transport and metabolism	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-376172	DSCAM interactions	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-211999	CYP2E1 reactions	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-193048	Androgen biosynthesis	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-71240	Tryptophan catabolism	0.999999999991434	-8.56638491821136e-12	11	0	0	336	8202
R-HSA-352230	Amino acid transport across the plasma membrane	0.999999999992208	-7.79217635251138e-12	31	0	0	336	8202
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.999999999992208	-7.79217635251138e-12	31	0	0	336	8202
R-HSA-70171	Glycolysis	0.999999999992208	-7.79217635251138e-12	31	0	0	336	8202
R-HSA-180746	Nuclear import of Rev protein	0.999999999992208	-7.79217635251138e-12	31	0	0	336	8202
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.999999999992208	-7.79217635251138e-12	31	0	0	336	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999992451	-7.54881651236392e-12	27	0	0	336	8202
R-HSA-192105	Synthesis of bile acids and bile salts	0.999999999992451	-7.54881651236392e-12	27	0	0	336	8202
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-418885	DCC mediated attractive signaling	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-5682910	LGI-ADAM interactions	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-69091	Polymerase switching	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-69109	Leading Strand Synthesis	0.999999999992515	-7.48516572750822e-12	14	0	0	336	8202
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999992899	-7.10067408091315e-12	33	0	0	336	8202
R-HSA-72187	mRNA 3'-end processing	0.999999999992899	-7.10067408091315e-12	33	0	0	336	8202
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999992901	-7.0994434140736e-12	23	0	0	336	8202
R-HSA-389948	PD-1 signaling	0.999999999992901	-7.0994434140736e-12	23	0	0	336	8202
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.999999999992901	-7.0994434140736e-12	23	0	0	336	8202
R-HSA-5627123	RHO GTPases activate PAKs	0.999999999992901	-7.0994434140736e-12	23	0	0	336	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999992901	-7.0994434140736e-12	23	0	0	336	8202
R-HSA-112409	RAF-independent MAPK1/3 activation	0.999999999992901	-7.0994434140736e-12	23	0	0	336	8202
R-HSA-5423646	Aflatoxin activation and detoxification	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-203765	eNOS activation and regulation	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-5205647	Mitophagy	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-166208	mTORC1-mediated signalling	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-202131	Metabolism of nitric oxide	0.999999999993244	-6.75609741422147e-12	22	0	0	336	8202
R-HSA-164944	Nef and signal transduction	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-1483115	Hydrolysis of LPC	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-73928	Depyrimidination	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-804914	Transport of fatty acids	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-196783	Coenzyme A biosynthesis	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-444821	Relaxin receptors	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-72731	Recycling of eIF2:GDP	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-192456	Digestion of dietary lipid	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999994122	-5.87794607738241e-12	8	0	0	336	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-5652084	Fructose metabolism	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-2161541	Abacavir metabolism	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-167827	The proton buffering model	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-444209	Free fatty acid receptors	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-114516	Disinhibition of SNARE formation	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-390651	Dopamine receptors	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-71032	Propionyl-CoA catabolism	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-187024	NGF-independant TRKA activation	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-157881	Cyclin B2 mediated events	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-561048	Organic anion transport	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-391906	Leukotriene receptors	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-68911	G2 Phase	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-426048	Arachidonate production from DAG	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-1169092	Activation of RAS in B cells	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-112307	Transmission across Electrical Synapses	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-167826	The fatty acid cycling model	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999994932	-5.06818111393562e-12	5	0	0	336	8202
R-HSA-375280	Amine ligand-binding receptors	0.999999999995371	-4.62939940427871e-12	42	0	0	336	8202
R-HSA-1461957	Beta defensins	0.999999999995371	-4.62939940427871e-12	42	0	0	336	8202
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999995818	-4.18181716365434e-12	32	0	0	336	8202
R-HSA-202433	Generation of second messenger molecules	0.999999999995818	-4.18181716365434e-12	32	0	0	336	8202
R-HSA-186712	Regulation of beta-cell development	0.999999999995818	-4.18181716365434e-12	32	0	0	336	8202
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.999999999995818	-4.18181716365434e-12	32	0	0	336	8202
R-HSA-73863	RNA Polymerase I Transcription Termination	0.999999999995818	-4.18181716365434e-12	32	0	0	336	8202
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999995818	-4.18181716365434e-12	32	0	0	336	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-173736	Alternative complement activation	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-1296061	HCN channels	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-75072	mRNA Editing	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-1296053	Classical Kir channels	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-888593	Reuptake of GABA	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-209563	Axonal growth stimulation	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-140179	Amine Oxidase reactions	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-428776	Class II GLUTs	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-165158	Activation of AKT2	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-442745	Activation of CaMK IV	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-390650	Histamine receptors	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-167060	NGF processing	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.999999999996061	-3.93882968326866e-12	4	0	0	336	8202
R-HSA-1474165	Reproduction	0.999999999996712	-3.28774603885423e-12	26	0	0	336	8202
R-HSA-975298	Ligand-gated ion channel transport	0.999999999996712	-3.28774603885423e-12	26	0	0	336	8202
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.999999999996712	-3.28774603885423e-12	26	0	0	336	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999996712	-3.28774603885423e-12	26	0	0	336	8202
R-HSA-1187000	Fertilization	0.999999999996712	-3.28774603885423e-12	26	0	0	336	8202
R-HSA-1251985	Nuclear signaling by ERBB4	0.999999999997124	-2.8759976433872e-12	40	0	0	336	8202
R-HSA-5675221	Negative regulation of MAPK pathway	0.999999999997124	-2.8759976433872e-12	40	0	0	336	8202
R-HSA-5673000	RAF activation	0.999999999997126	-2.87370797661439e-12	25	0	0	336	8202
R-HSA-5669034	TNFs bind their physiological receptors	0.999999999997126	-2.87370797661439e-12	25	0	0	336	8202
R-HSA-162588	Budding and maturation of HIV virion	0.999999999997126	-2.87370797661439e-12	25	0	0	336	8202
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.999999999997126	-2.87370797661439e-12	25	0	0	336	8202
R-HSA-380994	ATF4 activates genes	0.999999999997126	-2.87370797661439e-12	25	0	0	336	8202
R-HSA-3295583	TRP channels	0.999999999997126	-2.87370797661439e-12	25	0	0	336	8202
R-HSA-111996	Ca-dependent events	0.999999999998841	-1.15878404677322e-12	30	0	0	336	8202
R-HSA-157858	Gap junction trafficking and regulation	0.999999999998841	-1.15878404677322e-12	30	0	0	336	8202
R-HSA-174824	Lipoprotein metabolism	0.999999999998841	-1.15878404677322e-12	30	0	0	336	8202
R-HSA-420029	Tight junction interactions	0.999999999998841	-1.15878404677322e-12	30	0	0	336	8202
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-622312	Inflammasomes	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-69205	G1/S-Specific Transcription	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-1482925	Acyl chain remodelling of PG	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-164378	PKA activation in glucagon signalling	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-174800	Chylomicron-mediated lipid transport	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-432142	Platelet sensitization by LDL	0.999999999999872	-1.28395563473318e-13	17	0	0	336	8202
R-HSA-380259	Loss of Nlp from mitotic centrosomes	1.00000000000021	2.09544571118061e-13	63	0	0	336	8202
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	1.00000000000021	2.09544571118061e-13	63	0	0	336	8202
R-HSA-1489509	DAG and IP3 signaling	1.0000000000008	7.96285550841495e-13	34	0	0	336	8202
R-HSA-177243	Interactions of Rev with host cellular proteins	1.0000000000008	7.96285550841495e-13	34	0	0	336	8202
R-HSA-176033	Interactions of Vpr with host cellular proteins	1.0000000000008	7.96285550841495e-13	34	0	0	336	8202
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-199920	CREB phosphorylation	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-447038	NrCAM interactions	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-75158	TRAIL  signaling	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-429593	Inositol transporters	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-74182	Ketone body metabolism	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-448706	Interleukin-1 processing	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-164843	2-LTR circle formation	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000105	1.04913479047488e-12	7	0	0	336	8202
R-HSA-936837	Ion transport by P-type ATPases	1.00000000000274	2.7370077723478e-12	49	0	0	336	8202
R-HSA-171306	Packaging Of Telomere Ends	1.00000000000274	2.7370077723478e-12	49	0	0	336	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-156581	Methylation	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-203615	eNOS activation	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-451306	Ionotropic activity of Kainate Receptors	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-390666	Serotonin receptors	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-71384	Ethanol oxidation	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-211958	Miscellaneous substrates	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-176974	Unwinding of DNA	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-417957	P2Y receptors	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-202670	ERKs are inactivated	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-381033	ATF6-alpha activates chaperones	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000000292	2.9165743390266e-12	12	0	0	336	8202
R-HSA-1461973	Defensins	1.00000000000414	4.13920554822033e-12	51	0	0	336	8202
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.00000000000468	4.68116015132328e-12	35	0	0	336	8202
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.00000000000468	4.68116015132328e-12	35	0	0	336	8202
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000000479	4.79287936150473e-12	54	0	0	336	8202
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1.00000000000479	4.79287936150473e-12	54	0	0	336	8202
R-HSA-381753	Olfactory Signaling Pathway	1.00000000000534	5.34318337639734e-12	381	0	0	336	8202
R-HSA-1296072	Voltage gated Potassium channels	1.00000000000723	7.23414729088844e-12	43	0	0	336	8202
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-5218920	VEGFR2 mediated vascular permeability	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-190828	Gap junction trafficking	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-111933	Calmodulin induced events	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-381042	PERK regulates gene expression	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-111997	CaM pathway	1.0000000000083	8.29906068293319e-12	28	0	0	336	8202
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	1.00000000000855	8.54542308686016e-12	70	0	0	336	8202
R-HSA-774815	Nucleosome assembly	1.00000000000855	8.54542308686016e-12	70	0	0	336	8202
R-HSA-73923	Lipid digestion, mobilization, and transport	1.0000000000101	1.00953706601604e-11	60	0	0	336	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000001034	1.03378006465466e-11	56	0	0	336	8202
R-HSA-1502540	Signaling by Activin	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-209560	NF-kB is activated and signals survival	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-2029481	FCGR activation	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-350054	Notch-HLH transcription pathway	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-977441	GABA A receptor activation	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-5210891	Uptake and function of anthrax toxins	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-171007	p38MAPK events	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-74217	Purine salvage	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-209543	p75NTR recruits signalling complexes	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-209822	Glycoprotein hormones	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-75892	Platelet Adhesion to exposed collagen	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-175474	Assembly Of The HIV Virion	1.00000000001063	1.06256394723914e-11	13	0	0	336	8202
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-375170	CDO in myogenesis	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-5339562	Uptake and actions of bacterial toxins	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-445095	Interaction between L1 and Ankyrins	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-525793	Myogenesis	1.00000000001194	1.19440419053519e-11	29	0	0	336	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.0000000000135	1.34982810159034e-11	39	0	0	336	8202
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	1.0000000000135	1.34982810159034e-11	39	0	0	336	8202
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-211981	Xenobiotics	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-5621575	CD209 (DC-SIGN) signaling	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-198753	ERK/MAPK targets	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-156588	Glucuronidation	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-5620916	VxPx cargo-targeting to cilium	1.00000000001706	1.7060345087869e-11	21	0	0	336	8202
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000002061	2.06075051086992e-11	50	0	0	336	8202
